<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS201675</article-id><article-id pub-id-type="doi">10.1101/2024.11.29.625999</article-id><article-id pub-id-type="archive">PPR949152</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>NKG2A-mediated immune modulation of natural killer cells by <italic>Staphylococcus aureus</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Davies</surname><given-names>Kate</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rizek</surname><given-names>Al-Motaz</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kollnberger</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Eddie C. Y.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Eberl</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Underwood</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>McLaren</surname><given-names>James E.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK</aff><aff id="A2"><label>2</label>Systems Immunity University Research Institute, Cardiff University School of Medicine, Cardiff, UK</aff><aff id="A3"><label>3</label>Department of Infectious Diseases, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0489f6q08</institution-id><institution>Cardiff and Vale University Health Board</institution></institution-wrap>, <addr-line>Heath Park</addr-line>, <city>Cardiff</city>, <postal-code>CF14 4XW</postal-code>, <country country="GB">UK</country></aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author: <email>mclarenje@cardiff.ac.uk</email> (J.E.M.)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>05</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>03</day><month>12</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Natural killer (NK) cells are specialized lymphocytes that help protect against viruses and cancer. However, in the context of bacterial infections, NK cells can be harmful, rather than protective. Such immune pathogenesis by NK cells has been linked to the over-production of pro-inflammatory cytokines like interferon-γ (IFN-γ). In this context, IFN-γ-deficient mice display increased survival rates in response to <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>), which causes life-threatening, invasive systemic infections with high mortality rates in humans. However, little is known about how NK cells respond to <italic>S. aureus</italic> in humans. In this study, we found that the peripheral blood of patients with bloodstream <italic>S. aureus</italic> infection was enriched for NKG2A<sup>+</sup> NK cells with greater cytokine producing capacity, compared to those hospitalized with <italic>Escherichia coli</italic> bloodstream infections. As a possible mechanistic cause, superantigens from <italic>S. aureus</italic> promoted the expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells which produced IFN-γ through an IL-12-independent mechanism and exhibited reduced levels of CD16 compared to unstimulated NK cells. These data suggest that <italic>S. aureus</italic> bloodstream infection in humans promotes a phenotypic shift towards NKG2A<sup>+</sup> NK cells with greater IFN-γ producing capacity, providing a plausible way to promote inflammation-driven disease pathogenesis.</p></abstract><kwd-group><kwd>Natural killer cells</kwd><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>bacteraemia</kwd><kwd>NKG2A</kwd><kwd>superantigen</kwd><kwd>TSST-1</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2"><italic>Staphylococcus aureus</italic> is an opportunistic, Gram-positive bacterium which commonly exists as a commensal organism in humans asymptomatically colonising specific anatomical sites, such as the nasal mucosa(<xref ref-type="bibr" rid="R1">1</xref>), skin and gastrointestinal tract(<xref ref-type="bibr" rid="R2">2</xref>). Such residency requires the bacterium to overcome inbuilt host defence mechanisms, notably those orchestrated by innate (e.g. neutrophils) and adaptive (e.g. T cells) immune cells which provide major forms of protective immunity(<xref ref-type="bibr" rid="R3">3</xref>). This commensalism is a risk factor for the human host to develop life-threatening, invasive infections such as bloodstream infections (or “bacteraemia”) and endocarditis(<xref ref-type="bibr" rid="R4">4</xref>), which are associated with high mortality rates (30-day mortality at 20-30%)(<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R6">6</xref>). <italic>S. aureus</italic> is one of the most frequent causes of community- or hospital-acquired bacteraemia, second only to the Gram-negative bacterium <italic>Escherichia coli</italic> (<italic>E. coli</italic>)(<xref ref-type="bibr" rid="R7">7</xref>). <italic>S. aureus</italic> is also a leading cause of sepsis(<xref ref-type="bibr" rid="R8">8</xref>), a life-threatening condition caused by an exaggerated host immune response to infection that is estimated to underlie 1 in 5 deaths worldwide(<xref ref-type="bibr" rid="R9">9</xref>). Morbidity and mortality are exacerbated by its ability to establish deep-seated, metastatic infections despite seemingly effective antimicrobial therapy (<xref ref-type="bibr" rid="R10">10</xref>).</p><p id="P3">The inherent threat from <italic>S. aureus</italic> bacteraemia highlights the need to understand the pathophysiological interactions between this bacterium and the human immune system, including the immune evasive strategies that promote its persistence and survival. In this regard, <italic>S. aureus</italic> utilises a complex arsenal of virulence factors and immune evasion proteins that prevent immunological elimination by neutrophils, macrophages, T cells and antibodies(<xref ref-type="bibr" rid="R11">11</xref>). These include pore-forming toxins, such as leukocidin ED (LukED), Panton-Valentine leukocidin and α-hemolysin, which bind to and directly kill neutrophils, macrophages and/or T cells, and highly potent “superantigen” (SAg) exotoxins, which act to counteract and weaken host T cell defence mechanisms(<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref>). <italic>S. aureus</italic> is capable of producing 26 distinct SAgs encoded with mobile genetic elements including toxic shock syndrome (TSS) toxin-1 (TSST-1) and staphylococcal enterotoxins (SEs), such as SEA, SEB, and SEC1-3(<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref>). Distinct <italic>S. aureus</italic> strains can encode multiple SAgs, although rarely produce &gt;20 different SAgs at the same time (<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R17">17</xref>). SAgs primarily function by cross-linking T cell receptors on αβ T cells to major histocompatibility complex (MHC) class II molecules on the surface of antigen-presenting cells(<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R16">16</xref>). Such engagement causes SAgs to overstimulate T cells, leading to excessive cytokine release that may contribute to the propagation of a cytokine “storm” whilst simultaneously driving the upregulation of co-inhibitory receptors on T cells that renders them hyporesponsive(<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R18">18</xref>–<xref ref-type="bibr" rid="R21">21</xref>). Consequently, SAgs can drive life-threatening complications of <italic>S. aureus</italic> infection, such as TSS, necrotizing pneumonia and infective endocarditis(<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R22">22</xref>). SAgs can also bind costimulatory molecules(<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R26">26</xref>), cytokine receptors(<xref ref-type="bibr" rid="R27">27</xref>) and extracellular matrix proteins(<xref ref-type="bibr" rid="R28">28</xref>) on the surface of different cell types, providing additional mechanisms of action for immune evasion. SAgs have therefore become targets of therapeutic intervention(<xref ref-type="bibr" rid="R29">29</xref>, <xref ref-type="bibr" rid="R30">30</xref>) in an era of increasing antimicrobial resistance (e.g. methicillin-resistant <italic>S. aureus</italic>(<xref ref-type="bibr" rid="R31">31</xref>)) and the absence of a licenced vaccine against <italic>S. aureus</italic>.</p><p id="P4">Natural killer (NK) cells are innate immune cells of lymphocyte origin that play a specialist role in protecting the host against infectious pathogens and malignancy(<xref ref-type="bibr" rid="R32">32</xref>). Unlike T cells and B cells, NK cells lack somatically rearranged antigen receptors to mediate their function. Instead, NK cells utilize an array of germline-encoded activating and inhibitory receptors to recognize cell surface molecules of self or foreign origin, such as the killer cell immunoglobulin-like receptors (KIRs), natural cytotoxicity receptors (e.g. NKp30, NKp46), and the C-type lectin NKG2 receptors (e.g. NKG2A, NKG2C, NKG2D)(<xref ref-type="bibr" rid="R33">33</xref>). Human NK cells typically emerge into the circulation from secondary lymphoid organs as CD3<sup>−</sup> CD56<sup>hi</sup> CD16<sup>−</sup> cells(<xref ref-type="bibr" rid="R34">34</xref>) expressing high levels of NKp30, NKG2A and receptors for pro-inflammatory cytokines (e.g. interleukin-12 (IL-12), IL-18)(<xref ref-type="bibr" rid="R35">35</xref>). These CD56<sup>hi</sup> NK cells possess superior cytokine-producing capacity, despite having limited cytotoxic potential, but can differentiate into CD3<sup>−</sup> CD56<sup>dim</sup> CD16<sup>+</sup> subsets that predominate in the circulation and undergo phenotypic changes to specialize their function towards receptor-driven cytotoxicity(<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R36">36</xref>). These include expression of KIRs, CD57 and the activating NKG2C receptor whilst simultaneously losing NKG2A/CD94 expression(<xref ref-type="bibr" rid="R36">36</xref>–<xref ref-type="bibr" rid="R38">38</xref>). These highly differentiated NK cells can home to infected or dysregulated tissue sites to mediate their function, whilst many human organs retain populations of tissue-resident NK cells expressing established markers of residency(<xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R41">41</xref>). NK cell responses to acute or resolving viral infections are typically cytokine-driven, with less differentiated NK cells predominantly responding to IL-12, IL-15, IL-18 and type I interferons (IFNs) produced during infection which promote their survival, proliferation and effector function (e.g. through IFN-γ production)(<xref ref-type="bibr" rid="R35">35</xref>, <xref ref-type="bibr" rid="R42">42</xref>, <xref ref-type="bibr" rid="R43">43</xref>). However, in response to chronic infections, such as human cytomegalovirus (HCMV), more differentiated NK cells expand and develop adaptive features, akin to T cells, such as clonal expansion and the formation of immunological memory(<xref ref-type="bibr" rid="R44">44</xref>, <xref ref-type="bibr" rid="R45">45</xref>). These adaptive-like NK cell expansions typically express NKG2C and CD57(<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>). NK cells are essential for antiviral protection since patients with inborn NK cell deficiencies are highly prone to severe or recurrent herpesvirus infections(<xref ref-type="bibr" rid="R48">48</xref>).</p><p id="P5">In contrast to our knowledge of NK cell-mediated immunity to viruses, little is known about how NK cells respond to bacterial infections, especially in humans. NK cells can be activated by bacteria, directly through Toll-like receptors(<xref ref-type="bibr" rid="R49">49</xref>) or indirectly by pro-inflammatory cytokines produced by bacteria-sensing antigen presenting cells (e.g. dendritic cells)(<xref ref-type="bibr" rid="R50">50</xref>, <xref ref-type="bibr" rid="R51">51</xref>). NK cell-deficient mice have increased bacterial burden and poor immune control in response to <italic>Legionella pneumophilia</italic>(<xref ref-type="bibr" rid="R52">52</xref>) and <italic>Mycobacterium tuberculosis</italic>(<xref ref-type="bibr" rid="R53">53</xref>). Furthermore, NK cell-produced IFN-γ helps to promote bacterial elimination during various infections, including <italic>Klebsiella pneumoniae</italic>(<xref ref-type="bibr" rid="R52">52</xref>–<xref ref-type="bibr" rid="R54">54</xref>), whilst memory-like NK cells mediate protective immune responses to <italic>Streptococcus pneumoniae</italic>(<xref ref-type="bibr" rid="R55">55</xref>) and <italic>Ehrlichia muris</italic>(<xref ref-type="bibr" rid="R56">56</xref>). In contrast, NK cell-deficient or depleted mice have improved survival rates after <italic>E. coli</italic> or <italic>Streptococcus pyogenes</italic> infection, which has been linked to reduced levels of inflammation and lower production of pro-inflammatory cytokines, including IL-12 and IFN-γ(<xref ref-type="bibr" rid="R57">57</xref>, <xref ref-type="bibr" rid="R58">58</xref>). Furthermore, NK cells are thought to have a detrimental role in sepsis, including in immunocompromised hosts(<xref ref-type="bibr" rid="R59">59</xref>, <xref ref-type="bibr" rid="R60">60</xref>). This points to important pathogen-specific differences in the control and immunopathology of bacterial infections by NK cells. In the context of <italic>S. aureus</italic> infection, NK cells are in fact the major source of IFN-γ (<xref ref-type="bibr" rid="R61">61</xref>, <xref ref-type="bibr" rid="R62">62</xref>), and IFN-γ<sup>−/−</sup> mice or those treated with depleting anti IFN-γ antibodies are more resistant to lethal <italic>S. aureus</italic> challenge(<xref ref-type="bibr" rid="R63">63</xref>, <xref ref-type="bibr" rid="R64">64</xref>). The fact that SAgs(<xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref>) and other virulence factors such as the pore-forming toxins LukED(<xref ref-type="bibr" rid="R67">67</xref>), α-hemolysin(<xref ref-type="bibr" rid="R68">68</xref>) and β-hemolysin(<xref ref-type="bibr" rid="R69">69</xref>) alter the functionality of NK cells, including increasing their production of IFN-γ, suggests that NK cell-released IFN-γ could be a driver of immune pathogenesis during <italic>S. aureus</italic> infection. However, studies of NK cell responses to systemic <italic>S. aureus</italic> infections have been confined to animal models.</p><p id="P6">To address this knowledge gap, we here examined the NK cell response to <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia in humans. We found that more polyfunctional CD56<sup>dim</sup> NK cells with greater cytokine producing potential were observed in patients with <italic>S. aureus</italic> bacteraemia, compared to those hospitalized with <italic>E. coli</italic> bacteraemia. These highly responsive NK cells were enriched for NKG2A<sup>+</sup> subsets. In support of a possible underlying mechanism, SAgs, namely TSST-1, promoted the <italic>in vitro</italic> expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells that had reduced levels of CD16 and were capable of producing IFN-γ through an IL-12-independent mechanism. These data suggest that systemic <italic>S. aureus</italic> infection in humans promotes a phenotypic and functional shift towards IFN-γ producing NKG2A<sup>+</sup> NK cells, providing a plausible way to promote inflammation-driven disease pathogenesis.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Circulating NKG2A<sup>+</sup> NK cells increase in frequency <italic>in vivo</italic> during <italic>S. aureus</italic> bacteraemia</title><p id="P7">In order to study the NK cell response to <italic>S. aureus</italic>, we used multi-colour flow cytometry panels to identify and phenotype (Figure S1) NK cell subsets (e.g. CD56<sup>dim</sup> and CD56<sup>hi</sup> NK cells) in peripheral blood collected from adult patients hospitalized with <italic>S. aureus</italic> bacteraemia (<italic>n</italic> = 7) (<xref rid="F1" ref-type="fig">Figure 1A</xref>). Peripheral blood samples from adult patients hospitalized with <italic>E. coli</italic> bacteraemia (<italic>n</italic> = 8) and healthy controls (<italic>n</italic> = 8) were collected for comparison (<xref rid="T1" ref-type="table">Table 1</xref>). When assessing global NK cell frequency, patients with <italic>S. aureus</italic>, but not <italic>E. coli,</italic> bacteraemia had slightly lower frequencies of CD56<sup>dim</sup> NK cells compared to healthy controls, although these differences were not statistically significant (Figures S2A and S2B). Using NKG2A, NKG2C and CD57 as markers of different NK cell differentiation states, we discovered higher percentages of NKG2C<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls or patients with <italic>E. coli</italic> bacteraemia (<xref rid="F1" ref-type="fig">Figure 1B</xref>, <xref rid="F1" ref-type="fig">1C</xref> &amp; S3A). This increase in NKG2C<sup>−</sup> NKG2A<sup>+</sup> cells in <italic>S. aureus</italic> patients was NK cell-specific as it was not recapitulated in CD56<sup>+</sup> T cells (<xref rid="F1" ref-type="fig">Figure 1C</xref> &amp; S3B), which includes invariant-like subsets such as mucosal associated invariant T (MAIT) cells (<xref ref-type="bibr" rid="R70">70</xref>), where the percentage of NKG2C<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>+</sup> T cells was lower than in healthy controls. Furthermore, we found that, amongst all CD56<sup>dim</sup> NK cells, there was a slight increase in the percentage of CD57<sup>−</sup> NKG2A<sup>+</sup> and CD57<sup>+</sup> NKG2A<sup>+</sup> NK cells in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls (<xref rid="F1" ref-type="fig">Figure 1B</xref>, <xref rid="F1" ref-type="fig">1C</xref> &amp; S3C). In contrast, there was a significant decrease in CD57<sup>+</sup> NKG2A<sup>+</sup> CD56<sup>+</sup> T cells in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls (<xref rid="F1" ref-type="fig">Figure 1D</xref> &amp; S3D). In support of this subtle phenotypic change in NK cells, NKG2A expression levels were higher on CD56<sup>dim</sup> NK cells from <italic>S. aureus</italic> bacteraemia patients, compared to healthy controls and patients with <italic>E. coli</italic> bacteraemia, but we saw no change in CD57 expression (<xref rid="F1" ref-type="fig">Figure 1E</xref>). Paired analyses of CD56<sup>dim</sup> NK cells from PBMCs collected at hospital admission and approx. one month after hospital discharge (convalescence) demonstrated that this trend towards more NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells in <italic>S. aureus</italic> bacteraemia patients was sustained at convalescence, although some patients showed a reduction in the percentage of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells (Figures S3E &amp; S3F). IL-12 is known to upregulate NKG2A expression on NK cells (<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>). However, plasma IL-12p70 levels were lower in <italic>S. aureus</italic> bacteraemia patients compared to healthy controls and patients with <italic>E. coli</italic> bacteraemia (Figure S4A), despite a significant positive correlation between plasma IL-12p70 levels and the percentage of NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells in <italic>S. aureus</italic> patients (Figure S4B).</p><p id="P8">To further explore the significance of these NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cell-specific alterations in <italic>S. aureus</italic> patients, we assessed their activation status <italic>ex vivo</italic> using CD69 as a marker of NK cell activation. We found that there was an increase in the percentage of CD69<sup>+</sup> cells amongst NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls (Figure S5A). However, this increase in CD69<sup>+</sup> cells was similarly observed in NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells from patients with <italic>E. coli</italic> bacteraemia, but also within NKG2C<sup>+</sup> NKG2A<sup>−</sup> and global CD56<sup>dim</sup> NK cell populations in both patient groups (Figures S5A, S5B &amp; S5C). This suggested that the presence of either bacterial organism was driving a general increase in NK cell activation that was not restricted to NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells.</p><p id="P9">In contrast to data on CD69, <italic>S. aureus</italic>, but much less so <italic>E. coli,</italic> patients displayed a lower percentage of NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells expressing T-cell immunoglobulin and ITIM domain (TIGIT) compared to healthy controls (Figure S5D), a co-inhibitory receptor found on T cells and NK cells that can suppress NK cell-mediated cytokine production and cytotoxicity(<xref ref-type="bibr" rid="R73">73</xref>–<xref ref-type="bibr" rid="R76">76</xref>). An inverse correlation between the percentage of CD69<sup>+</sup> and TIGIT<sup>+</sup> cells was observed on NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells from controls or patients with <italic>E. coli</italic> bacteraemia. In contrast, in <italic>S. aureus</italic> patients, we identified a significant positive correlation between CD69 and TIGIT expression on NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells (Figure S5E). This trend in a reduction of TIGIT<sup>+</sup> cells was also observed amongst NKG2C<sup>+</sup> NKG2A<sup>−</sup> NK cells and global CD56<sup>dim</sup> NK cell populations in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls (Figures S5D &amp; S5F). Furthermore, a similar positive correlation between the percentage of CD69<sup>+</sup> and TIGIT<sup>+</sup> cells was observed when analysing the global CD56<sup>dim</sup> NK cell population (Figure S5G), which suggested that this association between CD69 and TIGIT positivity was more specific to the impact of <italic>S. aureus</italic> on all NK cells.</p><p id="P10">Adaptive-like NK cells typically represent highly differentiated CD57<sup>+</sup> NKG2C<sup>+</sup> populations that preferentially lack expression of NKp30 and the inhibitory receptor Siglec-7(<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>, <xref ref-type="bibr" rid="R77">77</xref>, <xref ref-type="bibr" rid="R78">78</xref>). Our data demonstrated a reduction in NKG2C<sup>+</sup> NKG2A<sup>−</sup> and CD57<sup>+</sup> NKG2A<sup>−</sup> CD56<sup>dim</sup> NK cells in <italic>S. aureus</italic> bacteraemia patients (<xref rid="F1" ref-type="fig">Figures 1C</xref>, S3A &amp; S3C) which might suggest that adaptive-like NK cell phenotypes could also be reduced in <italic>S. aureus</italic> bacteraemia patients. Indeed, we found the percentage of CD57<sup>+</sup> cells amongst NKG2C<sup>+</sup> NKG2A<sup>−</sup> CD56<sup>dim</sup> NK cells to be lower in <italic>S. aureus</italic> bacteraemia patients (<xref rid="F1" ref-type="fig">Figure 1F</xref>). Therefore, we next sought to determine whether NK cells with an adaptive-like phenotype were altered in <italic>S. aureus</italic> bacteraemia patients. After pre-gating on NKp30<sup>−</sup> Siglec-7<sup>−</sup> CD56<sup>dim</sup> NK cells, there was a reduction in the percentage of NKG2C<sup>+</sup> NKG2A<sup>−</sup> subsets in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls and <italic>E. coli</italic> bacteraemia patients (<xref rid="F2" ref-type="fig">Figures 2A</xref> &amp; <xref rid="F2" ref-type="fig">2B</xref>). In agreement with our data on all CD56<sup>dim</sup> NK cells, we also saw the proportion of NKG2C<sup>−</sup> NKG2A<sup>+</sup> and CD57<sup>−</sup> NKG2A<sup>+</sup> subsets increase in <italic>S. aureus</italic> bacteraemia patients (<xref rid="F2" ref-type="fig">Figures 2A</xref>, <xref rid="F2" ref-type="fig">2B</xref> &amp; <xref rid="F2" ref-type="fig">2C</xref>). Furthermore, the proportion of CD57<sup>+</sup> NKG2C<sup>+</sup> adaptive-like NK cells was lower in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls or <italic>E. coli</italic> patients (<xref rid="F2" ref-type="fig">Figure 2D</xref>).</p><p id="P11">Collectively, these data show that NKG2A<sup>+</sup> NK cells increase in frequency in patients with <italic>S. aureus</italic> bacteraemia, with a concurrent reduction in the percentage of CD57<sup>+</sup> NKG2C<sup>+</sup> adaptive-like NK cells.</p></sec><sec id="S4"><title>SAgs promote the expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells</title><p id="P12">Virulence factors encoded by <italic>S. aureus</italic> are capable of targeting NK cells and/or modifying their functionality(<xref ref-type="bibr" rid="R65">65</xref>–<xref ref-type="bibr" rid="R69">69</xref>). SAgs, which typically target T cells and HLA class II<sup>+</sup> APCs, can indirectly activate human NK cells, which produce more IFN-γ in response to SAg stimulation than innate-like T cell subsets such as MAIT cells(<xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref>). SAgs also promote the production of IL-12 from myeloid cells, which is important for inducing IFN-γ production, rather than cytotoxic granule release, from human NK cells(<xref ref-type="bibr" rid="R66">66</xref>, <xref ref-type="bibr" rid="R79">79</xref>, <xref ref-type="bibr" rid="R80">80</xref>). Given that IL-12 also upregulates NKG2A expression on both NK cells(<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>) and T cells(<xref ref-type="bibr" rid="R81">81</xref>), we next examined whether candidate SAgs from <italic>S. aureus</italic> could promote the formation of NKG2A<sup>+</sup> NK cells <italic>in vitro</italic>. Using PBMCs from healthy donors, stimulation with recombinant forms of SEA, SEB and TSST-1 (24h) produced significant increases in the percentage of IFN-γ<sup>+</sup>, CD107a<sup>+</sup> and CD69<sup>+</sup>CD56<sup>dim</sup> NK cells (Figures S6A, S6B, S6C &amp; S6D). Indeed, the degree of activation in CD56<sup>dim</sup> NK cells was comparable to that seen in CD56<sup>+</sup> T cells and higher than that seen in more conventional, CD56<sup>−</sup> T cells, in agreement with published data(<xref ref-type="bibr" rid="R66">66</xref>). Importantly though, all three SAgs promoted an increase in the percentage of NKG2C<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells, but also CD57<sup>−</sup> NKG2A<sup>+</sup> populations (<xref rid="F3" ref-type="fig">Figures 3A</xref>, <xref rid="F3" ref-type="fig">3B</xref>, S7A &amp; S7B). These effects were most evident following TSST-1 stimulation which yielded significant increases in the percentage of NKG2C<sup>−</sup> NKG2A<sup>+</sup> and CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells (<xref rid="F3" ref-type="fig">Figure 3B</xref>) but also in the expression levels of NKG2A on the surface of CD56<sup>dim</sup> NK cells (<xref rid="F3" ref-type="fig">Figure 3C</xref>). This effect was confined to CD56<sup>dim</sup> NK cells as all three SAgs yielded very little change in the percentage of NKG2C<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>hi</sup> NK cells, which were already at high levels (∼70%) in unstimulated cells (Figure S7C) whilst the proportion of CD57<sup>−</sup> NKG2A<sup>+</sup> cells within CD56<sup>hi</sup> NK cells even reduced upon stimulation (Figure S7D). The largest proportion of IFN-γ<sup>+</sup> CD56<sup>dim</sup> NK cells in response to SAg stimulation was confined to the CD57<sup>−</sup> NKG2C<sup>−</sup> NKG2A<sup>+</sup> subset (<xref rid="F3" ref-type="fig">Figure 3D</xref> &amp; S8). Furthermore, the percentage of TSST-1-induced IFN-γ<sup>+</sup> cells was significantly higher in CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells, compared to NKG2C<sup>+</sup> NKG2A<sup>−</sup> or CD57<sup>+</sup> NKG2A<sup>+</sup> NK cell subsets (<xref rid="F3" ref-type="fig">Figure 3E</xref>).</p><p id="P13">To explore the effects of SAg stimulation on CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cell subsets further, we examined longer stimulation time periods using TSST-1 as a candidate SAg to determine whether such phenotypic polarization was more pronounced over time. Indeed, the percentage of CD57<sup>−</sup> NKG2A<sup>+</sup> or NKG2C<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells continued to increase significantly following a period of 48h or 72h stimulation (<xref rid="F4" ref-type="fig">Figures 4A</xref> &amp; <xref rid="F4" ref-type="fig">4B</xref>). In line with these observations, NKG2A expression levels on the surface of CD56<sup>dim</sup> NK cells were significantly increased further following 48h or 72h stimulation (<xref rid="F4" ref-type="fig">Figure 4C</xref>). Furthermore, CD16 expression levels were significantly downregulated by TSST-1 stimulation on CD56<sup>dim</sup> NK cells and CD57<sup>−</sup> NKG2A<sup>+</sup> subsets, whilst CD56 expression also increased significantly over time with stimulation (<xref rid="F4" ref-type="fig">Figure 4C</xref> &amp; <xref rid="F4" ref-type="fig">4D</xref>). These changes were consistent with the notion of TSST-1 expanding a less differentiated NK cell phenotype upon stimulation. Additionally, the highest expression frequencies of the proliferation marker Ki67 were seen in CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells after 72h stimulation with TSST-1 (<xref rid="F4" ref-type="fig">Figure 4E</xref>).</p><p id="P14">Collectively, these data show that TSST-1 stimulation promotes the expansion of NKG2A<sup>+</sup> NK cells within human PBMCs, favouring highly proliferative, IFN-γ producing CD57<sup>−</sup> NKG2A<sup>+</sup> subsets whilst simultaneously driving a phenotypic shift towards this population.</p></sec><sec id="S5"><title>TSST-1-mediated promotion of a CD57<sup>-</sup>NKG2A<sup>+</sup> NK cell phenotype is IL-12-independent</title><p id="P15">IL-12 is known to upregulate NKG2A expression on NK cells(<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>). Thus, we next used an anti-IL-12p70 neutralizing antibody to determine if the increased percentage of CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells elicited after TSST-1 stimulation of PBMCs involved an IL-12-dependent mechanism. As expected, IL-12 blockade reduced the percentage of IFN-γ<sup>+</sup> CD56<sup>dim</sup> NK cells elicited after 48h stimulation with TSST-1 (Figures S9A &amp; S9B), agreeing with published data(<xref ref-type="bibr" rid="R66">66</xref>). However, neutralization of IL-12 had no discernible effect on the expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells that occurred after 48h TSST-1 stimulation (<xref rid="F5" ref-type="fig">Figures 5A</xref> &amp; <xref rid="F5" ref-type="fig">5B</xref>). TSST-1-mediated changes in the percentages of NKG2C<sup>−</sup> NKG2A<sup>+</sup> or CD57<sup>+</sup> NKG2A<sup>+</sup> subsets were also similarly unaffected by IL-12 blockade (<xref rid="F5" ref-type="fig">Figure 5B</xref>). In line with these observations, we saw no effect on NKG2A expression changes on the surface of CD56<sup>dim</sup> NK cells by TSST-1 (<xref rid="F5" ref-type="fig">Figure 5C</xref>). Furthermore, TSST-1-mediated changes in CD16 and CD56 expression were also IL-12-independent (<xref rid="F5" ref-type="fig">Figure 5C</xref>). These data suggest that whilst IL-12 is an important factor in SAg-induced IFN-γ production from CD56<sup>dim</sup> NK cells, it is not involved in driving CD56<sup>dim</sup> NK cells towards a CD57<sup>−</sup> NKG2A<sup>+</sup> NK cell phenotype.</p></sec><sec id="S6"><title>CD56<sup>dim</sup> NK cells in human patients with <italic>S. aureus</italic> bacteraemia are more polyfunctional</title><p id="P16">Peripheral blood NKG2A<sup>+</sup> NK cells are effective cytokine producers and differentiation towards CD57<sup>+</sup> NKG2C<sup>+</sup> populations generates NK cells that are less cytokine responsive but with more specialized functions such as receptor-driven cytotoxicity(<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R36">36</xref>–<xref ref-type="bibr" rid="R38">38</xref>). Furthermore, the co-inhibitory receptor TIGIT can engage target ligands such as CD155(<xref ref-type="bibr" rid="R73">73</xref>–<xref ref-type="bibr" rid="R76">76</xref>) and the TIGIT-CD155 axis can drive NK cells towards enhanced effector degranulation and cytokine production, notably against CD155<sup>-</sup> target cells (<xref ref-type="bibr" rid="R82">82</xref>). Our data demonstrates that NKG2A<sup>+</sup> NK cells expand during <italic>S. aureus</italic> bacteraemia and that a positive correlation exists between NK cell activation and TIGIT positivity on NK cells in these patients. As such, we hypothesized that <italic>S. aureus</italic> bacteraemia may generate NK cells with more degranulating and cytokine-producing capacity. To test this, we stimulated PBMCs collected from healthy controls and patients with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia (at hospital admission) with PMA/ionomycin (CD155-independent stimuli) and measured the percentage of CD56<sup>dim</sup> NK cells that degranulated (i.e. based on surface mobilization of CD107a(<sup><xref ref-type="bibr" rid="R83">83</xref></sup>)) and produced IFN-γ and/or TNF-α. We found that PMA/ionomycin stimulation yielded a significant increase in CD107a<sup>+</sup> CD56<sup>dim</sup> NK cells from patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls (<xref rid="F6" ref-type="fig">Figure 6A</xref>). In contrast, patients with <italic>E. coli</italic> bacteraemia had lower levels of CD107a<sup>+</sup> cells compared to that seen in <italic>S. aureus</italic> bacteraemia patients. A high proportion of CD107a<sup>+</sup> NK cells in <italic>S. aureus</italic> patients were IFN-γ<sup>+</sup> (<xref rid="F6" ref-type="fig">Figure 6B</xref>) and these CD107a<sup>+</sup> IFN-γ<sup>+</sup> NK cells were at significantly higher levels than those found in healthy controls (<xref rid="F6" ref-type="fig">Figure 6C</xref>). This suggested that patients with <italic>S. aureus</italic> bacteraemia may possess more polyfunctional NK cells, compared to healthy controls or patients with <italic>E. coli</italic> bacteraemia. Indeed, using Boolean gating and Simplified Presentation of Incredibly Complex Evaluations (SPICE) software(<xref ref-type="bibr" rid="R84">84</xref>) to assess the degree of NK cell polyfunctionality, patients with <italic>S. aureus</italic> bacteraemia displayed a higher proportion of polyfunctional CD56<sup>dim</sup> NK cells, compared to healthy controls or patients with <italic>E. coli</italic> bacteraemia (<xref rid="F6" ref-type="fig">Figure 6D</xref>). Furthermore, these <italic>S. aureus</italic> patients had fewer unresponsive CD56<sup>dim</sup> NK cells (CD107a<sup>−</sup> IFN-γ<sup>−</sup> TNF-α<sup>−</sup>) compared to healthy controls or patients with <italic>E. coli</italic> bacteraemia (<xref rid="F6" ref-type="fig">Figure 6D</xref>).</p><p id="P17">Collectively, these results demonstrate that CD56<sup>dim</sup> NK cells in patients with <italic>S. aureus</italic> bacteraemia are functionally more responsive to stimulation, yielding more polyfunctional NK cells, compared to healthy controls and those hospitalized with <italic>E. coli</italic> bacteraemia.</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P18">In this study, we observed an increase in the frequency of NKG2A<sup>+</sup> NK cells in patients with <italic>S. aureus</italic> bacteraemia compared to healthy controls and found that NK cells from these patients were functionally more responsive to stimulation, displaying evidence of being more polyfunctional and, thus, being capable of producing more effector cytokines, such as IFN-γ. Accordingly, our data suggest that systemic <italic>S. aureus</italic> infection in humans promotes a phenotypic shift towards NK cell subsets with greater IFN-γ producing capacity and notionally agrees with the concept that NK cells may promote inflammation-mediated disease pathogenesis during <italic>S. aureus</italic> bacteraemia. As far as we are aware, our study is the first to demonstrate this phenotypic alteration towards NKG2A<sup>+</sup> NK cells in this patient group and is consistent with studies in mouse models of <italic>S. aureus</italic> infection suggesting that NK cell-released IFN-γ may promote immune pathogenesis. In contrast, we did not observe the same alteration of NKG2A<sup>+</sup> NK cells in patients with <italic>E. coli</italic> bacteraemia, despite mouse models indicating that NK cells may also be immunopathogenic during systemic <italic>E. coli</italic> infection(<xref ref-type="bibr" rid="R57">57</xref>). This suggests that <italic>S. aureus</italic> itself may be directly responsible for triggering this change in the frequency of NKG2A<sup>+</sup> NK cells in patients. Indeed, our data shows that SAgs from <italic>S. aureus</italic>, namely TSST-1, can upregulate NKG2A expression on NK cells and promote the expansion of highly proliferative, IFN-γ producing CD57<sup>−</sup> NKG2A<sup>+</sup> subsets.</p><p id="P19">SAgs may not be the sole driver behind these phenotypic changes. <italic>S. aureus</italic> also encodes pore-forming toxins that affect NK cell behaviour, however, their effect on NKG2A expression is unknown and they are reported to deplete their frequencies(<xref ref-type="bibr" rid="R67">67</xref>) or inhibit their IFN-γ producing capacity(<xref ref-type="bibr" rid="R68">68</xref>). Beyond this, it is possible that unique features of the immune response to <italic>S. aureus</italic> may promote this increased frequency of NKG2A<sup>+</sup> NK cells. IL-12 can upregulate NKG2A expression on NK cells(<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>) yet we found that plasma IL-12p70 levels were lower in patients with <italic>S. aureus</italic> bacteraemia, compared to healthy controls or patients with <italic>E. coli</italic> bacteraemia. Transforming growth factor-β (TGF-β) is capable of increasing NKG2A expression on T cells(<xref ref-type="bibr" rid="R85">85</xref>) and TGF-β activation occurs in mouse models of <italic>S. aureus</italic> infection, principally through the actions of α-hemolysin (<xref ref-type="bibr" rid="R86">86</xref>). Thus, the increased frequency of NKG2A<sup>+</sup> NK cells could be mediated by TGF-β, although our observed reduction of NKG2C<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>+</sup> T cells in patients with <italic>S. aureus</italic> bacteraemia compared to healthy controls, would not be consistent with this. Nevertheless, expanding our understanding of how <italic>S. aureus</italic> modulates NK cell activity is important to determine whether these effects are exclusive to <italic>S. aureus</italic> or are observed during infection with other bacterial pathogens.</p><p id="P20">In conjunction with observing an increase in the frequency of NKG2A<sup>+</sup> NK cells in patients with <italic>S. aureus</italic> bacteraemia, we also detected a concurrent reduction in the percentage of CD57<sup>+</sup> NKG2C<sup>+</sup> NKp30<sup>−</sup> Siglec-7<sup>−</sup> NK cells compared to healthy controls and patients with <italic>E. coli</italic> bacteraemia. This phenotype has been used to define highly differentiated, adaptive-like NK cells that are proposed to contribute to antiviral protection and likely represent a host response to HCMV-encoded immune evasion (<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>, <xref ref-type="bibr" rid="R77">77</xref>, <xref ref-type="bibr" rid="R78">78</xref>). For instance, adaptive-like NK cells are also ILT2/LIR1<sup>+</sup> and CD2<sup>high</sup> (<xref ref-type="bibr" rid="R77">77</xref>, <xref ref-type="bibr" rid="R78">78</xref>, <xref ref-type="bibr" rid="R87">87</xref>), both of which are pathways targeted by the HCMV genes, UL18 and UL148 respectively(<xref ref-type="bibr" rid="R88">88</xref>, <xref ref-type="bibr" rid="R89">89</xref>). The NKG2A/NKG2C axis represents another. NKG2C, in complex with C-type lectin CD94, binds to, and is activated by, HLA-E(<xref ref-type="bibr" rid="R90">90</xref>), a non-classical major histocompatibility complex class I molecule that can present self and viral peptides, including polymorphic peptides derived from the HCMV-encoded UL40 protein to NK cells(<xref ref-type="bibr" rid="R91">91</xref>). However, NKG2A, which similarly dimerizes with CD94, also binds HLA-E but with greater affinity(<xref ref-type="bibr" rid="R90">90</xref>, <xref ref-type="bibr" rid="R92">92</xref>), but delivers an inhibitory signal to NKG2A<sup>+</sup> NK cells (<xref ref-type="bibr" rid="R93">93</xref>, <xref ref-type="bibr" rid="R94">94</xref>). In line with these concepts, it is plausible that <italic>S. aureus</italic> may also modulate HLA-E expression levels to evoke changes in the frequency of NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cell subsets. SAgs may also reduce the expression of HLA-E on different cell types including APCs releasing its inhibitory effect on NKG2A(<xref ref-type="bibr" rid="R95">95</xref>), and leading to greater activation of NKG2A<sup>+</sup> NK cell subsets and subsequent expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cell populations. The reduction in the percentage of CD57<sup>+</sup> NKG2C<sup>+</sup> NKp30<sup>-</sup> Siglec-7<sup>-</sup> NK cells may also be reflective of these cells being converted to NKG2A<sup>+</sup> NK cells, which also increased in frequency within NKp30<sup>-</sup> Siglec-7<sup>-</sup> NK cell populations. Further work is required to determine if this is a true feature of <italic>S. aureus</italic> infection but also how, and if, severe bacterial infections may affect adaptive-like NK cell populations.</p><p id="P21">The ability for SAgs from <italic>S. aureus</italic>, including TSST-1, to alter NK cell functionality has been reported before, notably in how they indirectly induce NK cells to produce high levels of IFN-γ through an IL-12-dependent mechanism (<xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref>). Whilst our data agree with these observations, we discovered that SAgs, notably TSST-1, promoted the expansion of highly proliferative, IFN-γ producing CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells with reduced CD16 expression, but, this process was not dependent on IL-12 even though SAgs promote IL-12 production from myeloid cells (<xref ref-type="bibr" rid="R66">66</xref>, <xref ref-type="bibr" rid="R79">79</xref>, <xref ref-type="bibr" rid="R80">80</xref>) and IL-12 itself can upregulate NKG2A expression on NK cells(<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>). Consequently, the core mechanism involved requires elucidation. TSST-1 has been shown to increase the percentage of NKG2A<sup>+</sup> T cells in time-course stimulation assays where PBMCs were depleted of CD94<sup>+</sup> cells (<xref ref-type="bibr" rid="R96">96</xref>). Furthermore, whilst these effects were relatively modest, even after 8-10 days of stimulation, co-culture with IL-15 or TGF-β amplified this process significantly(<xref ref-type="bibr" rid="R96">96</xref>, <xref ref-type="bibr" rid="R97">97</xref>). This suggested that TSST-1 was effective at converting NKG2A<sup>−</sup> T cells into NKG2A<sup>+</sup> T cells in tandem with IL-15 or TGF-β. Furthermore, IL-12 supplementation had no effect on this process(<xref ref-type="bibr" rid="R96">96</xref>). As such, our data on SAg-mediated changes in NK cells may reflect NKG2C<sup>−</sup> NKG2A<sup>−</sup> NK cells converting into NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cell subsets, rather than specific proliferation events occurring solely in pre-existing NKG2C<sup>−</sup> NKG2A<sup>+</sup> NK cells. However, it is worth noting that these T cell-based studies did not explore what factors were critical for TSST-1 being able to increase the percentage of NKG2A<sup>+</sup> T cells in the absence of supplemented co-factors such as IL-15 or TGF-β. Recently, it was shown that SEB-induced changes in NKG2A expression on CD8<sup>+</sup> T cells were impaired by CD40 blockade, which also prevented IL-12 production(<xref ref-type="bibr" rid="R98">98</xref>). Whilst it is still unknown if CD40 influences SAg-mediated changes in NKG2A expression on NK cells or the expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells seen in our experiments, it has been reported that SAgs can bind to CD40(<xref ref-type="bibr" rid="R26">26</xref>), which is found on APCs, and such binding could promote these phenotypic changes. Nonetheless, it will be important to dissect the critical factors that enable SAgs to increase the frequency of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells and compare such dependency patterns in T cells, where direct binding by SAgs to TCRs occurs. To this end, the notion that SAgs may directly bind NK cells(<xref ref-type="bibr" rid="R99">99</xref>) has been refuted since human NK cells alone appear to be unresponsive to SAgs, only occurring when T cells and monocytes are co-cultured with them (<xref ref-type="bibr" rid="R66">66</xref>).</p><p id="P22">Compared to what is known about NK cell-mediated immunity to viruses, our knowledge about how NK cells respond to bacterial infections is very limited and is complicated by the ambiguous nature of their precise role. Indeed, it appears that there are species-specific differences in the control and immunopathology of bacterial infections by NK cells. Our data on the NK cell response to <italic>S. aureus</italic> bacteraemia supports the concept that NK cells can promote immune pathology during bacterial infection and that this is linked to the impact of NK cell-derived production of IFN-γ, and likely other cytokines, in driving excessive inflammation. However, more evidence is needed to examine the precise role of NK cells across different types of bacterial infection in humans. Indeed, our study had some limitations, notably in the modest number of patients with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia that we enrolled but also that they were predominantly (for <italic>E. coli</italic>) or all (for <italic>S. aureus</italic>) female. Thus, larger longitudinal studies with better sex matching are needed to expand this further and learn more about NK cell-mediated inflammation to systemic <italic>S. aureus</italic> infection. This is perhaps even more relevant given the increased mortality risk seen in female patients with <italic>S. aureus</italic> bacteraemia(<xref ref-type="bibr" rid="R100">100</xref>, <xref ref-type="bibr" rid="R101">101</xref>), which ultimately means a better understanding of sex-specific nuances in NK cell-mediated immunity is even more crucial. Furthermore, it will be important to compare findings with data collected from patients with bloodstream infections caused by other bacterial organisms.</p><p id="P23">In summary, we observed an increase in polyfunctional CD56<sup>dim</sup> NK cells with greater cytokine producing potential in patients with <italic>S. aureus</italic> bacteraemia. These patients also exhibited increased frequencies of NKG2A<sup>+</sup> NK cell subsets, whilst SAgs from <italic>S. aureus</italic> promoted the expansion of IFN-γ producing, CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells through an IL-12-independent mechanism. As such, our data supports the concept that immune pathogenesis during <italic>S. aureus</italic> infection may be linked to over-production of pro-inflammatory cytokines and that alterations in NK cell-released IFN-γ could be a driver of immune pathogenesis during <italic>S. aureus</italic> infection. These mechanisms require further elucidation but imply that therapeutic approaches combining immune modulatory agents with antibiotics need to be explored.</p></sec><sec id="S8" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S9"><title>Subjects and ethical approval</title><p id="P24">The recruitment of adult patients admitted to the University Hospital of Wales with invasive bloodstream <italic>S. aureus</italic> or <italic>E. coli</italic> infections (bacteraemia) was approved by the NHS Research Ethics Committee (reference 21/WA/0202, IRAS project ID 277598) and was sponsored by Cardiff University and Cardiff &amp; Vale University Health Board. All participants provided written informed consent for the collection of peripheral blood samples and subsequent analyses in accordance with the principles of the Declaration of Helsinki. Patients were excluded if they were pregnant, breastfeeding or females of childbearing age in whom a pregnancy test had not been performed. Furthermore, participants considered too unwell, with limited life expectancy, with mental incapacity or language barriers which preclude adequate understanding or those with an estimated glomerular filtration rate &lt;45 ml/min/1.73m<sup>2</sup> where excluded. The study cohort comprised patients with microbiologically confirmed <italic>S. aureus</italic> (age ranging from 27 to 79 years (median 63 years)) or <italic>E. coli</italic> (age ranging from 31 to 74 years (median 68 years)) bacteraemia. Peripheral venous blood samples were collected from bacteraemia patients at hospital admission (within 2-6 days post-diagnosis) from patients with <italic>S. aureus</italic> (<italic>n</italic> = 7; median 3 days post-diagnosis) or <italic>E. coli</italic> (<italic>n</italic> = 8; median 3 days post-diagnosis) bacteraemia. Matched donor blood samples collected at convalescence (as close to 30 days post-hospital discharge as possible) were collected from <italic>n</italic> = 4 patients with <italic>S. aureus</italic> bacteraemia and <italic>n</italic> = 8 patients with <italic>E. coli</italic> bacteraemia. Healthy control blood donors (<italic>n</italic> = 8; age range 59–72 years, median 66 years) were recruited as controls for the study if there was no history of recent (&lt;1 year) bloodstream <italic>S. aureus</italic> or <italic>E. coli</italic> infections, were over the age of 18, had the capacity to consent or in the event of temporarily reduced capacity, consent from the next-of-kin (or another suitable consultee) was gained. Peripheral venous blood samples were collected from healthy controls (<italic>n</italic> = 8) at point of enrolment. For experimental assays not involving bacteraemia patients and study controls (i.e. experiments involving <italic>in vitro</italic> SAg stimulation assays), peripheral venous blood samples were collected from healthy volunteers and buffy coats purchased from the Welsh Blood Service. The use of venous blood samples from healthy volunteers was approved by the Cardiff University School of Medicine Research Ethics Committee (18/4). Written informed consent was obtained from all donors in accordance with the principles of the Declaration of Helsinki.</p></sec><sec id="S10"><title>Cell culture and <italic>in vitro</italic> stimulation assays</title><p id="P25">Human peripheral blood mononuclear cells (PBMCs) were isolated via density gradient centrifugation using Histopaque-1077 (Sigma-Aldrich) and cryopreserved in foetal bovine serum containing 10% dimethyl sulfoxide (Sigma-Aldrich). Human PBMCs were thawed and rested in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mM L-glutamine (all from Thermo Fisher Scientific) (R10) at 37°C and in 5% CO<sub>2</sub> prior to being seeded in 24-well or 96-well culture plates for <italic>in vitro</italic> stimulation assays. Cell Activation Cocktail (BioLegend) was used to deliver 25 ng/ml phorbol-12-myristate 13-acetate (PMA) and 500 ng/ml ionomycin to cultured PBMCs for 6h at 37°C. Recombinant forms of SEA, SEB or TSST-1 from <italic>S. aureus</italic> (Toxin Technology), each at a dose of 100 ng/mL to align with previous work(<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R102">102</xref>–<xref ref-type="bibr" rid="R104">104</xref>), were used to stimulate PBMCs for 24h, unless otherwise stated. Unstimulated cells were used as negative controls. In mechanistic experiments, human PBMCs were preincubated for 30 min with 2 μg/mL anti-human IL-12 (clone 24910; BioTechne) or 2 μg/mL mouse IgG<sub>1</sub> (clone MOPC-21; BioLegend). In functional experiments, anti-CD107a–BV421 (clone H4A3; BioLegend) was added to the cultures with PMA/ionomycin or each individual SAg(<xref ref-type="bibr" rid="R105">105</xref>), and protein transport was blocked for the final 6h with GolgiPlug (1:1,000; BD Biosciences) and GolgiStop (1:1,500; BD Biosciences).</p></sec><sec id="S11"><title>Flow cytometry</title><p id="P26">Cells were washed in Dulbecco’s phosphate-buffered saline (Thermo Fisher Scientific), labelled for 15–30 min at room temperature with Zombie Aqua (BioLegend) for live/dead cell exclusion. Surface stains were performed for 30 min at 4°C using combinations of the following directly conjugated monoclonal antibodies: (i) anti-CD3–APC/Fire 750 (clone SK7), anti-CD3–PerCP (clone SK7), anti-CD14–APC/Fire 750 (clone M5E2), anti-CD16–BV711 (clone 3G8), anti-CD56–BV605 (clone HCD56), anti-CD56–BV711 (clone HCD56), anti-CD57–PE/Dazzle 594 (clone QA17A04), anti-CD69–APC (clone FN50), anti-CD69–BV421 (clone FN50, anti-NKG2C–PE (clone S19005E), anti-NKp30–APC/Fire 750 (clone P30-15), anti-Siglec-7–APC/Fire 750 (clone 6-434) and anti-TIGIT-BV421 (clone A15153G) from BioLegend; (ii) anti-CD14 V500 (clone M5E2) and anti-CD19 V500 (clone HIB19) from BD Biosciences; and (iii) anti-NKG2A-VioBright FITC (clone REA110) from Miltenyi Biotec. Cytosolic/intranuclear expression of Ki67 was detected using anti-Ki67–BV421 (clone B56; BD Biosciences) in conjunction with a FOXP3 Transcription Factor Staining Buffer Kit (Thermo Fisher Scientific). Intracellular cytokines were exposed using a Cytofix/Cytoperm Plus Fixation/Permeabilization Solution Kit (BD Biosciences) or FOXP3 Transcription Factor Staining Buffer Kit (Thermo Fisher Scientific) and stained for 30 min at 4 °C with combinations of the following directly conjugated monoclonal antibodies: anti-IFN-γ–APC (clone B27), anti-IFN-γ–PE/Cyanine7 (clone B27) and anti-TNF-α–APC (clone MAb11) from BioLegend. All flow cytometry panels were validated using individually stained anti-mouse Ig, k/Negative Control Particles (BD Biosciences) or MACS anti-REA Comp Bead kit (Miltenyi Biotec). Data were acquired using an Attune NxT flow cytometer (Thermo Fisher Scientific) and analyzed using FlowJo software version 10.10 (FlowJo LLC).</p></sec><sec id="S12"><title>IL-12p70-specific ELISA</title><p id="P27">Plasma was collected from patients with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia and healthy controls during the density gradient centrifugation of peripheral blood using Histopaque-1077. Aliquots were prepared and stored at −80 °C until further use. IL-12p70 levels were quantified using a commercial ELISA kit (Mabtech). Nunc MaxiSorp 96-well plates (BioLegend) were coated with an anti-IL-12p40 capture antibody (2 μg/ml; Mabtech clone MT86/221) and incubated overnight at 4°C. Following incubation, plates were blocked with PBS supplemented with 0.1% bovine serum albumin and 0.05% Tween-20 (Sigma Aldrich)) for 1h at room temperature (RT) to reduce non-specific binding. Following this, coated plates were washed three times with PBS containing 0.05% Tween-20 before undiluted plasma samples and recombinant IL-12p70 protein (serially diluted from 1 ng/ml after preparation from a stock concentration of 1 μg/ml to prepare a standard curve) were added in duplicate and incubated for 2h at RT. After further washing, plates were incubated for 1h at RT with a biotin conjugated anti-IL-12p70 detection antibody (1 μg/ml; Mabtech clone MT704) diluted to 1 μg/ml before the process was repeated using streptavidin conjugated to alkaline phosphatase (Mabtech; 1:1000 dilution of stock protein). Following further washing with PBS containing 0.05% Tween-20, Para-nitrophenylphosphate (Mabtech) was added to each well and incubated for 60 mins at RT to develop in the absence of light. Optical densities were read at 405nm using the CLARIOstar microplate reader (BMG Labtech). Samples were blinded to eliminate operator bias. Standard curves were plotted using a nonlinear regression model on Prism (GraphPad v10.1.0), with concentrations calculated in reference to the curve. All recombinant IL-12p70 protein standard and human plasma sample aliquots were thawed immediately prior to use.</p></sec><sec id="S13"><title>Statistics</title><p id="P28">Differences between two groups were evaluated using a Mann-Whitney U-test whilst differences between three or more groups were evaluated using a one-way ANOVA with Tukey’s post-hoc test in Prism version 8.3.1 (GraphPad). Analysis of paired samples was performed using Wilcoxon matched-pairs sign ranked test whilst tests of correlation between two variables were performed using Spearman’s rank correlation test. Significance was assigned at p&lt;0.05 and depicted in figures with asterisk where achieved.</p></sec></sec></body><back><ack id="S14"><title>Acknowledgements</title><p><xref rid="F1" ref-type="fig">Figure 1A</xref> was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender.com</ext-link>.</p><sec id="S15"><title>Funding</title><p>This work was supported by grant funding from the Royal Society (RGS\R2\222186). KD is supported by a Medical Research Council GW4 BioMed2 Doctoral Training Partnership studentship. SK is funded as a co-investigator on Medical Research Council grant (MR/V000489/1). All flow cytometric assays were analyzed on a ThermoFisher Attune NxT flow cytometer which was obtained and serviced with the following grants awarded to ECYW - MR/P001602/1, MR/S00971X/1, MR/V000489/1, and Wellcome Trust grants 204870 (awarded to P Griffiths, UCL) and 207503/Z/17/Z (awarded to I Humphreys, Cardiff University). JU is supported by the Medical Research Council (grant number MR/T023791/1).</p></sec></ack><fn-group><fn id="FN1" fn-type="con"><p id="P29"><bold>Author Contributions</bold></p><p id="P30">KD: Investigation, Formal Analysis, Resources, Validation, Visualization Writing – Review &amp; Editing</p><p id="P31">AR: Investigation, Formal Analysis</p><p id="P32">SK: Conceptualization, Methodology, Writing – Review &amp; Editing</p><p id="P33">ECYW: Conceptualization, Methodology, Writing – Review &amp; Editing</p><p id="P34">ME: Supervision, Resources, Writing – Review &amp; Editing</p><p id="P35">JU: Conceptualization, Funding Acquisition, Project Administration, Resources, Writing – Review &amp; Editing</p><p id="P36">JEM: Conceptualization, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review &amp; Editing</p></fn><fn id="FN2" fn-type="conflict"><p id="P37"><bold>Conflict of Interest Statement</bold></p><p id="P38">The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakr</surname><given-names>A</given-names></name><name><surname>Bregeon</surname><given-names>F</given-names></name><name><surname>Mege</surname><given-names>JL</given-names></name><name><surname>Rolain</surname><given-names>JM</given-names></name><name><surname>Blin</surname><given-names>O</given-names></name></person-group><article-title>Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>2419</fpage><pub-id pub-id-type="pmcid">PMC6186810</pub-id><pub-id pub-id-type="pmid">30349525</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.02419</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RE</given-names></name></person-group><article-title>Healthy carriage of Staphylococcus aureus: its prevalence and importance</article-title><source>Bacteriol Rev</source><year>1963</year><volume>27</volume><issue>1</issue><fpage>56</fpage><lpage>71</lpage><pub-id pub-id-type="pmcid">PMC441169</pub-id><pub-id pub-id-type="pmid">14000926</pub-id><pub-id pub-id-type="doi">10.1128/br.27.1.56-71.1963</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Giulieri</surname><given-names>SG</given-names></name><name><surname>Wong Fok Lung</surname><given-names>T</given-names></name><name><surname>Baines</surname><given-names>SL</given-names></name><name><surname>Sharkey</surname><given-names>LK</given-names></name><name><surname>Lee</surname><given-names>JYH</given-names></name><etal/></person-group><article-title>Staphylococcus aureus host interactions and adaptation</article-title><source>Nat Rev Microbiol</source><year>2023</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC9882747</pub-id><pub-id pub-id-type="pmid">36707725</pub-id><pub-id pub-id-type="doi">10.1038/s41579-023-00852-y</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowy</surname><given-names>FD</given-names></name></person-group><article-title>Staphylococcus aureus infections</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><issue>8</issue><fpage>520</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9709046</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiecinski</surname><given-names>JM</given-names></name><name><surname>Horswill</surname><given-names>AR</given-names></name></person-group><article-title>Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms</article-title><source>Curr Opin Microbiol</source><year>2020</year><volume>53</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="pmcid">PMC7244392</pub-id><pub-id pub-id-type="pmid">32172183</pub-id><pub-id pub-id-type="doi">10.1016/j.mib.2020.02.005</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underwood</surname><given-names>J</given-names></name><name><surname>Griffiths</surname><given-names>R</given-names></name><name><surname>Gillespie</surname><given-names>D</given-names></name><name><surname>Akbari</surname><given-names>A</given-names></name><name><surname>Ahmed</surname><given-names>H</given-names></name></person-group><article-title>All-cause and Infection-attributable Mortality Amongst Adults With Bloodstream Infection-a Population-based Study</article-title><source>Open Forum Infect Dis</source><year>2024</year><volume>11</volume><issue>5</issue><elocation-id>ofae126</elocation-id><pub-id pub-id-type="pmcid">PMC11055210</pub-id><pub-id pub-id-type="pmid">38680606</pub-id><pub-id pub-id-type="doi">10.1093/ofid/ofae126</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonten</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>JR</given-names></name><name><surname>van den Biggelaar</surname><given-names>AHJ</given-names></name><name><surname>Georgalis</surname><given-names>L</given-names></name><name><surname>Geurtsen</surname><given-names>J</given-names></name><name><surname>de Palacios</surname><given-names>PI</given-names></name><etal/></person-group><article-title>Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review</article-title><source>Clin Infect Dis</source><year>2021</year><volume>72</volume><issue>7</issue><fpage>1211</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">32406495</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Rello</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Silva</surname><given-names>E</given-names></name><name><surname>Anzueto</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>CD</given-names></name><etal/></person-group><article-title>International study of the prevalence and outcomes of infection in intensive care units</article-title><source>JAMA</source><year>2009</year><volume>302</volume><issue>21</issue><fpage>2323</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19952319</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname><given-names>KE</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Agesa</surname><given-names>KM</given-names></name><name><surname>Shackelford</surname><given-names>KA</given-names></name><name><surname>Tsoi</surname><given-names>D</given-names></name><name><surname>Kievlan</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><issue>10219</issue><fpage>200</fpage><lpage>11</lpage><pub-id pub-id-type="pmcid">PMC6970225</pub-id><pub-id pub-id-type="pmid">31954465</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaasch</surname><given-names>AJ</given-names></name><name><surname>Barlow</surname><given-names>G</given-names></name><name><surname>Edgeworth</surname><given-names>JD</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names><suffix>Jr</suffix></name><name><surname>Hellmich</surname><given-names>M</given-names></name><name><surname>Hopkins</surname><given-names>S</given-names></name><etal/></person-group><article-title>Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies</article-title><source>J Infect</source><year>2014</year><volume>68</volume><issue>3</issue><fpage>242</fpage><lpage>51</lpage><pub-id pub-id-type="pmcid">PMC4136490</pub-id><pub-id pub-id-type="pmid">24247070</pub-id><pub-id pub-id-type="doi">10.1016/j.jinf.2013.10.015</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thammavongsa</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Missiakas</surname><given-names>D</given-names></name><name><surname>Schneewind</surname><given-names>O</given-names></name></person-group><article-title>Staphylococcal manipulation of host immune responses</article-title><source>Nat Rev Microbiol</source><year>2015</year><volume>13</volume><issue>9</issue><fpage>529</fpage><lpage>43</lpage><pub-id pub-id-type="pmcid">PMC4625792</pub-id><pub-id pub-id-type="pmid">26272408</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro3521</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappin</surname><given-names>E</given-names></name><name><surname>Ferguson</surname><given-names>AJ</given-names></name></person-group><article-title>Gram-positive toxic shock syndromes</article-title><source>Lancet Infect Dis</source><year>2009</year><volume>9</volume><issue>5</issue><fpage>281</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">19393958</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>DE</given-names></name></person-group><article-title>Toxic shock syndrome: major advances in pathogenesis, but not treatment</article-title><source>Crit Care Clin</source><year>2013</year><volume>29</volume><issue>3</issue><fpage>651</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">23830657</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>FR</given-names></name><name><surname>McLaren</surname><given-names>JE</given-names></name></person-group><article-title>T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>17</issue><pub-id pub-id-type="pmcid">PMC7504484</pub-id><pub-id pub-id-type="pmid">32858901</pub-id><pub-id pub-id-type="doi">10.3390/ijms21176144</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaulding</surname><given-names>AR</given-names></name><name><surname>Salgado-Pabon</surname><given-names>W</given-names></name><name><surname>Kohler</surname><given-names>PL</given-names></name><name><surname>Horswill</surname><given-names>AR</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name><name><surname>Schlievert</surname><given-names>PM</given-names></name></person-group><article-title>Staphylococcal and streptococcal superantigen exotoxins</article-title><source>Clin Microbiol Rev</source><year>2013</year><volume>26</volume><issue>3</issue><fpage>422</fpage><lpage>47</lpage><pub-id pub-id-type="pmcid">PMC3719495</pub-id><pub-id pub-id-type="pmid">23824366</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00104-12</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuffs</surname><given-names>SW</given-names></name><name><surname>Dufresne</surname><given-names>K</given-names></name><name><surname>Rishi</surname><given-names>A</given-names></name><name><surname>Walton</surname><given-names>NR</given-names></name><name><surname>McCormick</surname><given-names>JK</given-names></name></person-group><article-title>Novel insights into the immune response to bacterial T cell superantigens</article-title><source>Nat Rev Immunol</source><year>2024</year><pub-id pub-id-type="pmid">38225276</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlievert</surname><given-names>PM</given-names></name><name><surname>Case</surname><given-names>LC</given-names></name><name><surname>Strandberg</surname><given-names>KL</given-names></name><name><surname>Abrams</surname><given-names>BB</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name></person-group><article-title>Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis</article-title><source>Clin Infect Dis</source><year>2008</year><volume>46</volume><issue>10</issue><fpage>1562</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC2637450</pub-id><pub-id pub-id-type="pmid">18419342</pub-id><pub-id pub-id-type="doi">10.1086/586746</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>J</given-names></name><name><surname>Herman</surname><given-names>A</given-names></name><name><surname>Pullen</surname><given-names>AM</given-names></name><name><surname>Kubo</surname><given-names>R</given-names></name><name><surname>Kappler</surname><given-names>JW</given-names></name><name><surname>Marrack</surname><given-names>P</given-names></name></person-group><article-title>The V-Beta-Specific Superantigen Staphylococcal Enterotoxin-B - Stimulation of Mature T-Cells and Clonal Deletion in Neonatal Mice</article-title><source>Cell</source><year>1989</year><volume>56</volume><issue>1</issue><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">2521300</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaler</surname><given-names>CR</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Rudak</surname><given-names>PT</given-names></name><name><surname>Memarnejadian</surname><given-names>A</given-names></name><name><surname>Szabo</surname><given-names>PA</given-names></name><name><surname>Tun-Abraham</surname><given-names>ME</given-names></name><etal/></person-group><article-title>MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression</article-title><source>Plos Biology</source><year>2017</year><volume>15</volume><issue>6</issue><pub-id pub-id-type="pmcid">PMC5478099</pub-id><pub-id pub-id-type="pmid">28632753</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2001930</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabe</surname><given-names>Y</given-names></name><name><surname>Ochi</surname><given-names>A</given-names></name></person-group><article-title>Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice</article-title><source>J Exp Med</source><year>1990</year><volume>172</volume><issue>4</issue><fpage>1065</fpage><lpage>70</lpage><pub-id pub-id-type="pmcid">PMC2188597</pub-id><pub-id pub-id-type="pmid">1976734</pub-id><pub-id pub-id-type="doi">10.1084/jem.172.4.1065</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajgenbaum</surname><given-names>DC</given-names></name><name><surname>June</surname><given-names>CH</given-names></name></person-group><article-title>Cytokine Storm</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>23</issue><fpage>2255</fpage><lpage>73</lpage><pub-id pub-id-type="pmcid">PMC7727315</pub-id><pub-id pub-id-type="pmid">33264547</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra2026131</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuffs</surname><given-names>SW</given-names></name><name><surname>Goncheva</surname><given-names>MI</given-names></name><name><surname>Xu</surname><given-names>SX</given-names></name><name><surname>Craig</surname><given-names>HC</given-names></name><name><surname>Kasper</surname><given-names>KJ</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Superantigens promote Staphylococcus aureus bloodstream infection by eliciting pathogenic interferon-gamma production</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><volume>119</volume><issue>8</issue><pub-id pub-id-type="pmcid">PMC8872782</pub-id><pub-id pub-id-type="pmid">35165181</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2115987119</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arad</surname><given-names>G</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Nasie</surname><given-names>I</given-names></name><name><surname>Hillman</surname><given-names>D</given-names></name><name><surname>Rotfogel</surname><given-names>Z</given-names></name><name><surname>Barash</surname><given-names>U</given-names></name><etal/></person-group><article-title>Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock</article-title><source>PLoS Biol</source><year>2011</year><volume>9</volume><issue>9</issue><elocation-id>e1001149</elocation-id><pub-id pub-id-type="pmcid">PMC3172200</pub-id><pub-id pub-id-type="pmid">21931534</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001149</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popugailo</surname><given-names>A</given-names></name><name><surname>Rotfogel</surname><given-names>Z</given-names></name><name><surname>Supper</surname><given-names>E</given-names></name><name><surname>Hillman</surname><given-names>D</given-names></name><name><surname>Kaempfer</surname><given-names>R</given-names></name></person-group><article-title>Staphylococcal and Streptococcal Superantigens Trigger B7/CD28 Costimulatory Receptor Engagement to Hyperinduce Inflammatory Cytokines</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>942</fpage><pub-id pub-id-type="pmcid">PMC6503043</pub-id><pub-id pub-id-type="pmid">31114583</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00942</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Rotfogel</surname><given-names>Z</given-names></name><name><surname>Hillman</surname><given-names>D</given-names></name><name><surname>Popugailo</surname><given-names>A</given-names></name><name><surname>Arad</surname><given-names>G</given-names></name><name><surname>Supper</surname><given-names>E</given-names></name><etal/></person-group><article-title>Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><issue>42</issue><fpage>E6437</fpage><lpage>E46</lpage><pub-id pub-id-type="pmcid">PMC5081635</pub-id><pub-id pub-id-type="pmid">27708164</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1603321113</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaulding</surname><given-names>AR</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Merriman</surname><given-names>JA</given-names></name><name><surname>Brosnahan</surname><given-names>AJ</given-names></name><name><surname>Peterson</surname><given-names>ML</given-names></name><name><surname>Schlievert</surname><given-names>PM</given-names></name></person-group><article-title>Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><issue>34</issue><fpage>5099</fpage><lpage>109</lpage><pub-id pub-id-type="pmcid">PMC3397198</pub-id><pub-id pub-id-type="pmid">22691432</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.05.067</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banke</surname><given-names>E</given-names></name><name><surname>Rodstrom</surname><given-names>K</given-names></name><name><surname>Ekelund</surname><given-names>M</given-names></name><name><surname>Dalla-Riva</surname><given-names>J</given-names></name><name><surname>Lagerstedt</surname><given-names>JO</given-names></name><name><surname>Nilsson</surname><given-names>S</given-names></name><etal/></person-group><article-title>Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism</article-title><source>Metabolism</source><year>2014</year><volume>63</volume><issue>6</issue><fpage>831</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">24684823</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zeppa</surname><given-names>JJ</given-names></name><name><surname>Hancock</surname><given-names>MA</given-names></name><name><surname>McCormick</surname><given-names>JK</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name><name><surname>Hendy</surname><given-names>GN</given-names></name><etal/></person-group><article-title>Staphylococcal Superantigens Use LAMA2 as a Coreceptor To Activate T Cells</article-title><source>J Immunol</source><year>2018</year><volume>200</volume><issue>4</issue><fpage>1471</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">29335257</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Karauzum</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>H</given-names></name><name><surname>Carranza</surname><given-names>D</given-names></name><name><surname>Holtsberg</surname><given-names>FW</given-names></name><name><surname>Howell</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Potent Neutralization of Staphylococcal Enterotoxin B In Vivo by Antibodies that Block Binding to the T-Cell Receptor</article-title><source>J Mol Biol</source><year>2019</year><volume>431</volume><issue>21</issue><fpage>4354</fpage><lpage>67</lpage><pub-id pub-id-type="pmcid">PMC6764902</pub-id><pub-id pub-id-type="pmid">30928493</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2019.03.017</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WH</given-names></name><name><surname>Pasetti</surname><given-names>MF</given-names></name><name><surname>Adhikari</surname><given-names>RP</given-names></name><name><surname>Baughman</surname><given-names>H</given-names></name><name><surname>Douglas</surname><given-names>R</given-names></name><name><surname>El-Khorazaty</surname><given-names>J</given-names></name><etal/></person-group><article-title>Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax</article-title><source>Clin Vaccine Immunol</source><year>2016</year><volume>23</volume><issue>12</issue><fpage>918</fpage><lpage>25</lpage><pub-id pub-id-type="pmcid">PMC5139602</pub-id><pub-id pub-id-type="pmid">27707765</pub-id><pub-id pub-id-type="doi">10.1128/CVI.00399-16</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>HF</given-names></name><name><surname>Deleo</surname><given-names>FR</given-names></name></person-group><article-title>Waves of resistance: Staphylococcus aureus in the antibiotic era</article-title><source>Nat Rev Microbiol</source><year>2009</year><volume>7</volume><issue>9</issue><fpage>629</fpage><lpage>41</lpage><pub-id pub-id-type="pmcid">PMC2871281</pub-id><pub-id pub-id-type="pmid">19680247</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro2200</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivier</surname><given-names>E</given-names></name><name><surname>Tomasello</surname><given-names>E</given-names></name><name><surname>Baratin</surname><given-names>M</given-names></name><name><surname>Walzer</surname><given-names>T</given-names></name><name><surname>Ugolini</surname><given-names>S</given-names></name></person-group><article-title>Functions of natural killer cells</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><issue>5</issue><fpage>503</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">18425107</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>NK cell recognition</article-title><source>Annu Rev Immunol</source><year>2005</year><volume>23</volume><fpage>225</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15771571</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freud</surname><given-names>AG</given-names></name><name><surname>Becknell</surname><given-names>B</given-names></name><name><surname>Roychowdhury</surname><given-names>S</given-names></name><name><surname>Mao</surname><given-names>HC</given-names></name><name><surname>Ferketich</surname><given-names>AK</given-names></name><name><surname>Nuovo</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells</article-title><source>Immunity</source><year>2005</year><volume>22</volume><issue>3</issue><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">15780987</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjorkstrom</surname><given-names>NK</given-names></name><name><surname>Strunz</surname><given-names>B</given-names></name><name><surname>Ljunggren</surname><given-names>HG</given-names></name></person-group><article-title>Natural killer cells in antiviral immunity</article-title><source>Nat Rev Immunol</source><year>2022</year><volume>22</volume><issue>2</issue><fpage>112</fpage><lpage>23</lpage><pub-id pub-id-type="pmcid">PMC8194386</pub-id><pub-id pub-id-type="pmid">34117484</pub-id><pub-id pub-id-type="doi">10.1038/s41577-021-00558-3</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjorkstrom</surname><given-names>NK</given-names></name><name><surname>Riese</surname><given-names>P</given-names></name><name><surname>Heuts</surname><given-names>F</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Fauriat</surname><given-names>C</given-names></name><name><surname>Ivarsson</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education</article-title><source>Blood</source><year>2010</year><volume>116</volume><issue>19</issue><fpage>3853</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">20696944</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Verges</surname><given-names>S</given-names></name><name><surname>Milush</surname><given-names>JM</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>York</surname><given-names>VA</given-names></name><name><surname>Arakawa-Hoyt</surname><given-names>J</given-names></name><name><surname>Pircher</surname><given-names>H</given-names></name><etal/></person-group><article-title>CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset</article-title><source>Blood</source><year>2010</year><volume>116</volume><issue>19</issue><fpage>3865</fpage><lpage>74</lpage><pub-id pub-id-type="pmcid">PMC2981540</pub-id><pub-id pub-id-type="pmid">20733159</pub-id><pub-id pub-id-type="doi">10.1182/blood-2010-04-282301</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Mao</surname><given-names>HC</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Hughes</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>IK</given-names></name><etal/></person-group><article-title>CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets</article-title><source>Blood</source><year>2010</year><volume>115</volume><issue>2</issue><fpage>274</fpage><lpage>81</lpage><pub-id pub-id-type="pmcid">PMC2808153</pub-id><pub-id pub-id-type="pmid">19897577</pub-id><pub-id pub-id-type="doi">10.1182/blood-2009-04-215491</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dogra</surname><given-names>P</given-names></name><name><surname>Rancan</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Toth</surname><given-names>M</given-names></name><name><surname>Senda</surname><given-names>T</given-names></name><name><surname>Carpenter</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Tissue Determinants of Human NK Cell Development, Function, and Residence</article-title><source>Cell</source><year>2020</year><volume>180</volume><issue>4</issue><fpage>749</fpage><lpage>63</lpage><elocation-id>e13</elocation-id><pub-id pub-id-type="pmcid">PMC7194029</pub-id><pub-id pub-id-type="pmid">32059780</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.01.022</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquardt</surname><given-names>N</given-names></name><name><surname>Beziat</surname><given-names>V</given-names></name><name><surname>Nystrom</surname><given-names>S</given-names></name><name><surname>Hengst</surname><given-names>J</given-names></name><name><surname>Ivarsson</surname><given-names>MA</given-names></name><name><surname>Kekalainen</surname><given-names>E</given-names></name><etal/></person-group><article-title>Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells</article-title><source>J Immunol</source><year>2015</year><volume>194</volume><issue>6</issue><fpage>2467</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">25672754</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquardt</surname><given-names>N</given-names></name><name><surname>Kekalainen</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Lourda</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>JN</given-names></name><name><surname>Scharenberg</surname><given-names>M</given-names></name><etal/></person-group><article-title>Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><issue>1</issue><elocation-id>3841</elocation-id><pub-id pub-id-type="pmcid">PMC6710242</pub-id><pub-id pub-id-type="pmid">31451696</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-11632-9</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauriat</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>EO</given-names></name><name><surname>Ljunggren</surname><given-names>HG</given-names></name><name><surname>Bryceson</surname><given-names>YT</given-names></name></person-group><article-title>Regulation of human NK-cell cytokine and chemokine production by target cell recognition</article-title><source>Blood</source><year>2010</year><volume>115</volume><issue>11</issue><fpage>2167</fpage><lpage>76</lpage><pub-id pub-id-type="pmcid">PMC2844017</pub-id><pub-id pub-id-type="pmid">19965656</pub-id><pub-id pub-id-type="doi">10.1182/blood-2009-08-238469</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name></person-group><article-title>Developmental and Functional Control of Natural Killer Cells by Cytokines</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>930</fpage><pub-id pub-id-type="pmcid">PMC5543290</pub-id><pub-id pub-id-type="pmid">28824650</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.00930</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerwenka</surname><given-names>A</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>Natural killer cell memory in infection, inflammation and cancer</article-title><source>Nat Rev Immunol</source><year>2016</year><volume>16</volume><issue>2</issue><fpage>112</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">26806484</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Beilke</surname><given-names>JN</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>Adaptive immune features of natural killer cells</article-title><source>Nature</source><year>2009</year><volume>457</volume><issue>7229</issue><fpage>557</fpage><lpage>61</lpage><pub-id pub-id-type="pmcid">PMC2674434</pub-id><pub-id pub-id-type="pmid">19136945</pub-id><pub-id pub-id-type="doi">10.1038/nature07665</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guma</surname><given-names>M</given-names></name><name><surname>Budt</surname><given-names>M</given-names></name><name><surname>Saez</surname><given-names>A</given-names></name><name><surname>Brckalo</surname><given-names>T</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Angulo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts</article-title><source>Blood</source><year>2006</year><volume>107</volume><issue>9</issue><fpage>3624</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">16384928</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Verges</surname><given-names>S</given-names></name><name><surname>Milush</surname><given-names>JM</given-names></name><name><surname>Schwartz</surname><given-names>BS</given-names></name><name><surname>Pando</surname><given-names>MJ</given-names></name><name><surname>Jarjoura</surname><given-names>J</given-names></name><name><surname>York</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><issue>36</issue><fpage>14725</fpage><lpage>32</lpage><pub-id pub-id-type="pmcid">PMC3169160</pub-id><pub-id pub-id-type="pmid">21825173</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1110900108</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orange</surname><given-names>JS</given-names></name></person-group><article-title>Natural killer cell deficiency</article-title><source>J Allergy Clin Immunol</source><year>2013</year><volume>132</volume><issue>3</issue><fpage>515</fpage><lpage>25</lpage><pub-id pub-id-type="pmcid">PMC3917661</pub-id><pub-id pub-id-type="pmid">23993353</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2013.07.020</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauzon</surname><given-names>NM</given-names></name><name><surname>Mian</surname><given-names>F</given-names></name><name><surname>Ashkar</surname><given-names>AA</given-names></name></person-group><article-title>Toll-like receptors, natural killer cells and innate immunity</article-title><source>Adv Exp Med Biol</source><year>2007</year><volume>598</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17892200</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>KC</given-names></name><name><surname>Riley</surname><given-names>EM</given-names></name></person-group><article-title>Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens</article-title><source>Nat Rev Immunol</source><year>2007</year><volume>7</volume><issue>4</issue><fpage>279</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">17380157</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanoni</surname><given-names>I</given-names></name><name><surname>Spreafico</surname><given-names>R</given-names></name><name><surname>Bodio</surname><given-names>C</given-names></name><name><surname>Di Gioia</surname><given-names>M</given-names></name><name><surname>Cigni</surname><given-names>C</given-names></name><name><surname>Broggi</surname><given-names>A</given-names></name><etal/></person-group><article-title>IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions</article-title><source>Cell Rep</source><year>2013</year><volume>4</volume><issue>6</issue><fpage>1235</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">24055061</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sporri</surname><given-names>R</given-names></name><name><surname>Joller</surname><given-names>N</given-names></name><name><surname>Albers</surname><given-names>U</given-names></name><name><surname>Hilbi</surname><given-names>H</given-names></name><name><surname>Oxenius</surname><given-names>A</given-names></name></person-group><article-title>MyD88-dependent IFN-gamma production by NK cells is key for control of Legionella pneumophila infection</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><issue>10</issue><fpage>6162</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16670325</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Kaviratne</surname><given-names>M</given-names></name><name><surname>Rothfuchs</surname><given-names>AG</given-names></name><name><surname>Cheever</surname><given-names>A</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>HA</given-names></name><etal/></person-group><article-title>NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><issue>10</issue><fpage>7086</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17082625</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivin</surname><given-names>M</given-names></name><name><surname>Dumigan</surname><given-names>A</given-names></name><name><surname>de Vasconcelos</surname><given-names>FN</given-names></name><name><surname>Ebner</surname><given-names>F</given-names></name><name><surname>Borroni</surname><given-names>M</given-names></name><name><surname>Kavirayani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection</article-title><source>PLoS Pathog</source><year>2017</year><volume>13</volume><issue>11</issue><elocation-id>e1006696</elocation-id><pub-id pub-id-type="pmcid">PMC5675380</pub-id><pub-id pub-id-type="pmid">29112952</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006696</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camarasa</surname><given-names>TMN</given-names></name><name><surname>Torne</surname><given-names>J</given-names></name><name><surname>Chevalier</surname><given-names>C</given-names></name><name><surname>Rasid</surname><given-names>O</given-names></name><name><surname>Hamon</surname><given-names>MA</given-names></name></person-group><article-title>Streptococcus pneumoniae drives specific and lasting Natural Killer cell memory</article-title><source>PLoS Pathog</source><year>2023</year><volume>19</volume><issue>7</issue><elocation-id>e1011159</elocation-id><pub-id pub-id-type="pmcid">PMC10399893</pub-id><pub-id pub-id-type="pmid">37486946</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1011159</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>S</given-names></name><name><surname>El Andaloussi</surname><given-names>A</given-names></name><name><surname>Hisham</surname><given-names>A</given-names></name><name><surname>Ismail</surname><given-names>N</given-names></name></person-group><article-title>NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><issue>4</issue><elocation-id>e0153223</elocation-id><pub-id pub-id-type="pmcid">PMC4836677</pub-id><pub-id pub-id-type="pmid">27092553</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0153223</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badgwell</surname><given-names>B</given-names></name><name><surname>Parihar</surname><given-names>R</given-names></name><name><surname>Magro</surname><given-names>C</given-names></name><name><surname>Dierksheide</surname><given-names>J</given-names></name><name><surname>Russo</surname><given-names>T</given-names></name><name><surname>Carson</surname><given-names>WE</given-names></name></person-group><article-title>Natural killer cells contribute to the lethality of a murine model of infection</article-title><source>Surgery</source><year>2002</year><volume>132</volume><issue>2</issue><fpage>205</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">12219013</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldmann</surname><given-names>O</given-names></name><name><surname>Chhatwal</surname><given-names>GS</given-names></name><name><surname>Medina</surname><given-names>E</given-names></name></person-group><article-title>Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><issue>8</issue><fpage>1280</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15776374</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etogo</surname><given-names>AO</given-names></name><name><surname>Nunez</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Toliver-Kinsky</surname><given-names>TE</given-names></name><name><surname>Sherwood</surname><given-names>ER</given-names></name></person-group><article-title>NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><issue>9</issue><fpage>6334</fpage><lpage>45</lpage><pub-id pub-id-type="pmcid">PMC3413484</pub-id><pub-id pub-id-type="pmid">18424757</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.180.9.6334</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>AR</given-names></name><name><surname>Kirkham</surname><given-names>LA</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name><name><surname>Andrew</surname><given-names>PW</given-names></name><name><surname>Garside</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>H</given-names></name><etal/></person-group><article-title>Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts</article-title><source>Microbes Infect</source><year>2005</year><volume>7</volume><issue>5-6</issue><fpage>845</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">15893495</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>QT</given-names></name><name><surname>Furuya</surname><given-names>Y</given-names></name><name><surname>Roberts</surname><given-names>S</given-names></name><name><surname>Metzger</surname><given-names>DW</given-names></name></person-group><article-title>Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><issue>10</issue><fpage>6308</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC4576051</pub-id><pub-id pub-id-type="pmid">26248370</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00968-15</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghimire</surname><given-names>L</given-names></name><name><surname>Paudel</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Baral</surname><given-names>P</given-names></name><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Jeyaseelan</surname><given-names>S</given-names></name></person-group><article-title>NLRP6 negatively regulates pulmonary host defense in Gram-positive bacterial infection through modulating neutrophil recruitment and function</article-title><source>PLoS Pathog</source><year>2018</year><volume>14</volume><issue>9</issue><elocation-id>e1007308</elocation-id><pub-id pub-id-type="pmcid">PMC6171945</pub-id><pub-id pub-id-type="pmid">30248149</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007308</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Mizuki</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Madarame</surname><given-names>H</given-names></name><etal/></person-group><article-title>Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><issue>5</issue><fpage>2424</fpage><lpage>30</lpage><pub-id pub-id-type="pmcid">PMC97441</pub-id><pub-id pub-id-type="pmid">10768926</pub-id><pub-id pub-id-type="doi">10.1128/iai.68.5.2424-2430.2000</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakane</surname><given-names>A</given-names></name><name><surname>Okamoto</surname><given-names>M</given-names></name><name><surname>Asano</surname><given-names>M</given-names></name><name><surname>Kohanawa</surname><given-names>M</given-names></name><name><surname>Minagawa</surname><given-names>T</given-names></name></person-group><article-title>Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice</article-title><source>Infect Immun</source><year>1995</year><volume>63</volume><issue>4</issue><fpage>1165</fpage><lpage>72</lpage><pub-id pub-id-type="pmcid">PMC173129</pub-id><pub-id pub-id-type="pmid">7890367</pub-id><pub-id pub-id-type="doi">10.1128/iai.63.4.1165-1172.1995</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ami</surname><given-names>K</given-names></name><name><surname>Ohkawa</surname><given-names>T</given-names></name><name><surname>Koike</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Habu</surname><given-names>Y</given-names></name><name><surname>Iwai</surname><given-names>T</given-names></name><etal/></person-group><article-title>Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18</article-title><source>Clin Exp Immunol</source><year>2002</year><volume>128</volume><issue>3</issue><fpage>453</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC1906263</pub-id><pub-id pub-id-type="pmid">12109440</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2249.2002.01854.x</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata Forsberg</surname><given-names>M</given-names></name><name><surname>Arasa</surname><given-names>C</given-names></name><name><surname>van Zwol</surname><given-names>W</given-names></name><name><surname>Uzuncayir</surname><given-names>S</given-names></name><name><surname>Schonbichler</surname><given-names>A</given-names></name><name><surname>Regenthal</surname><given-names>P</given-names></name><etal/></person-group><article-title>Activation of human gammadelta T cells and NK cells by Staphylococcal enterotoxins requires both monocytes and conventional T cells</article-title><source>J Leukoc Biol</source><year>2022</year><volume>111</volume><issue>3</issue><fpage>597</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">34114693</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulouis</surname><given-names>C</given-names></name><name><surname>Leeansyah</surname><given-names>E</given-names></name><name><surname>Mairpady Shambat</surname><given-names>S</given-names></name><name><surname>Norrby-Teglund</surname><given-names>A</given-names></name><name><surname>Sandberg</surname><given-names>JK</given-names></name></person-group><article-title>Mucosa-Associated Invariant T Cell Hypersensitivity to Staphylococcus aureus Leukocidin ED and Its Modulation by Activation</article-title><source>J Immunol</source><year>2022</year><pub-id pub-id-type="pmcid">PMC9012079</pub-id><pub-id pub-id-type="pmid">35140134</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.2100912</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>TS</given-names></name><name><surname>Hilliard</surname><given-names>JJ</given-names></name><name><surname>Jones-Nelson</surname><given-names>O</given-names></name><name><surname>Keller</surname><given-names>AE</given-names></name><name><surname>O’Day</surname><given-names>T</given-names></name><name><surname>Tkaczyk</surname><given-names>C</given-names></name><etal/></person-group><article-title>Staphylococcus aureus alpha toxin potentiates opportunistic bacterial lung infections</article-title><source>Sci Transl Med</source><year>2016</year><volume>8</volume><issue>329</issue><elocation-id>329ra31</elocation-id><pub-id pub-id-type="pmid">26962155</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name></person-group><article-title>Staphylococcus aureus beta-Hemolysin Up-Regulates the Expression of IFN-gamma by Human CD56(bright) NK Cells</article-title><source>Front Cell Infect Microbiol</source><year>2021</year><volume>11</volume><elocation-id>658141</elocation-id><pub-id pub-id-type="pmcid">PMC8039520</pub-id><pub-id pub-id-type="pmid">33854984</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.658141</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>J</given-names></name><name><surname>Leeansyah</surname><given-names>E</given-names></name><name><surname>Sandberg</surname><given-names>JK</given-names></name></person-group><article-title>Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines</article-title><source>Proc Natl Acad Sci U S A</source><year>2017</year><volume>114</volume><issue>27</issue><fpage>E5434</fpage><lpage>E43</lpage><pub-id pub-id-type="pmcid">PMC5502643</pub-id><pub-id pub-id-type="pmid">28630305</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1705759114</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draghi</surname><given-names>M</given-names></name><name><surname>Yawata</surname><given-names>N</given-names></name><name><surname>Gleimer</surname><given-names>M</given-names></name><name><surname>Yawata</surname><given-names>M</given-names></name><name><surname>Valiante</surname><given-names>NM</given-names></name><name><surname>Parham</surname><given-names>P</given-names></name></person-group><article-title>Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I</article-title><source>Blood</source><year>2005</year><volume>105</volume><issue>5</issue><fpage>2028</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">15528315</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saez-Borderias</surname><given-names>A</given-names></name><name><surname>Romo</surname><given-names>N</given-names></name><name><surname>Magri</surname><given-names>G</given-names></name><name><surname>Guma</surname><given-names>M</given-names></name><name><surname>Angulo</surname><given-names>A</given-names></name><name><surname>Lopez-Botet</surname><given-names>M</given-names></name></person-group><article-title>IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><issue>2</issue><fpage>829</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">19124726</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanietsky</surname><given-names>N</given-names></name><name><surname>Simic</surname><given-names>H</given-names></name><name><surname>Arapovic</surname><given-names>J</given-names></name><name><surname>Toporik</surname><given-names>A</given-names></name><name><surname>Levy</surname><given-names>O</given-names></name><name><surname>Novik</surname><given-names>A</given-names></name><etal/></person-group><article-title>The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>42</issue><fpage>17858</fpage><lpage>63</lpage><pub-id pub-id-type="pmcid">PMC2764881</pub-id><pub-id pub-id-type="pmid">19815499</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0903474106</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Harden</surname><given-names>K</given-names></name><name><surname>Gonzalez</surname><given-names>LC</given-names></name><name><surname>Francesco</surname><given-names>M</given-names></name><name><surname>Chiang</surname><given-names>E</given-names></name><name><surname>Irving</surname><given-names>B</given-names></name><etal/></person-group><article-title>The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells</article-title><source>Nat Immunol</source><year>2009</year><volume>10</volume><issue>1</issue><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">19011627</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling</article-title><source>J Biol Chem</source><year>2014</year><volume>289</volume><issue>25</issue><fpage>17647</fpage><lpage>57</lpage><pub-id pub-id-type="pmcid">PMC4067199</pub-id><pub-id pub-id-type="pmid">24817116</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M114.572420</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanietsky</surname><given-names>N</given-names></name><name><surname>Rovis</surname><given-names>TL</given-names></name><name><surname>Glasner</surname><given-names>A</given-names></name><name><surname>Seidel</surname><given-names>E</given-names></name><name><surname>Tsukerman</surname><given-names>P</given-names></name><name><surname>Yamin</surname><given-names>R</given-names></name><etal/></person-group><article-title>Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR</article-title><source>Eur J Immunol</source><year>2013</year><volume>43</volume><issue>8</issue><fpage>2138</fpage><lpage>50</lpage><pub-id pub-id-type="pmcid">PMC3863769</pub-id><pub-id pub-id-type="pmid">23677581</pub-id><pub-id pub-id-type="doi">10.1002/eji.201243072</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beziat</surname><given-names>V</given-names></name><name><surname>Dalgard</surname><given-names>O</given-names></name><name><surname>Asselah</surname><given-names>T</given-names></name><name><surname>Halfon</surname><given-names>P</given-names></name><name><surname>Bedossa</surname><given-names>P</given-names></name><name><surname>Boudifa</surname><given-names>A</given-names></name><etal/></person-group><article-title>CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients</article-title><source>Eur J Immunol</source><year>2012</year><volume>42</volume><issue>2</issue><fpage>447</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">22105371</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beziat</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>LL</given-names></name><name><surname>Malmberg</surname><given-names>JA</given-names></name><name><surname>Ivarsson</surname><given-names>MA</given-names></name><name><surname>Sohlberg</surname><given-names>E</given-names></name><name><surname>Bjorklund</surname><given-names>AT</given-names></name><etal/></person-group><article-title>NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs</article-title><source>Blood</source><year>2013</year><volume>121</volume><issue>14</issue><fpage>2678</fpage><lpage>88</lpage><pub-id pub-id-type="pmcid">PMC3617633</pub-id><pub-id pub-id-type="pmid">23325834</pub-id><pub-id pub-id-type="doi">10.1182/blood-2012-10-459545</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Sriram</surname><given-names>S</given-names></name></person-group><article-title>Induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB</article-title><source>Cell Immunol</source><year>2000</year><volume>199</volume><issue>1</issue><fpage>50</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10675275</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haraguchi</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>NK</given-names></name><name><surname>Nelson</surname><given-names>RP</given-names><suffix>Jr</suffix></name><name><surname>Emmanuel</surname><given-names>P</given-names></name><name><surname>Duplantier</surname><given-names>JE</given-names></name><name><surname>Christodoulou</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Interleukin 12 deficiency associated with recurrent infections</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><issue>22</issue><fpage>13125</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC23732</pub-id><pub-id pub-id-type="pmid">9789052</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.22.13125</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derre</surname><given-names>L</given-names></name><name><surname>Corvaisier</surname><given-names>M</given-names></name><name><surname>Pandolfino</surname><given-names>MC</given-names></name><name><surname>Diez</surname><given-names>E</given-names></name><name><surname>Jotereau</surname><given-names>F</given-names></name><name><surname>Gervois</surname><given-names>N</given-names></name></person-group><article-title>Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><issue>10</issue><fpage>4864</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11994435</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Ljunggren</surname><given-names>HG</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name><etal/></person-group><article-title>Contribution of inhibitory receptor TIGIT to NK cell education</article-title><source>J Autoimmun</source><year>2017</year><volume>81</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">28438433</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alter</surname><given-names>G</given-names></name><name><surname>Malenfant</surname><given-names>JM</given-names></name><name><surname>Altfeld</surname><given-names>M</given-names></name></person-group><article-title>CD107a as a functional marker for the identification of natural killer cell activity</article-title><source>J Immunol Methods</source><year>2004</year><volume>294</volume><issue>1-2</issue><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15604012</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roederer</surname><given-names>M</given-names></name><name><surname>Nozzi</surname><given-names>JL</given-names></name><name><surname>Nason</surname><given-names>MC</given-names></name></person-group><article-title>SPICE: exploration and analysis of post-cytometric complex multivariate datasets</article-title><source>Cytometry A</source><year>2011</year><volume>79</volume><issue>2</issue><fpage>167</fpage><lpage>74</lpage><pub-id pub-id-type="pmcid">PMC3072288</pub-id><pub-id pub-id-type="pmid">21265010</pub-id><pub-id pub-id-type="doi">10.1002/cyto.a.21015</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunturi</surname><given-names>A</given-names></name><name><surname>Berg</surname><given-names>RE</given-names></name><name><surname>Crossley</surname><given-names>E</given-names></name><name><surname>Murray</surname><given-names>S</given-names></name><name><surname>Forman</surname><given-names>J</given-names></name></person-group><article-title>The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells</article-title><source>Eur J Immunol</source><year>2005</year><volume>35</volume><issue>3</issue><fpage>766</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">15714583</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>TS</given-names></name><name><surname>Takahashi</surname><given-names>V</given-names></name><name><surname>Bonnell</surname><given-names>J</given-names></name><name><surname>Tovchigrechko</surname><given-names>A</given-names></name><name><surname>Chaerkady</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Staphylococcus aureus drives expansion of low-density neutrophils in diabetic mice</article-title><source>J Clin Invest</source><year>2019</year><volume>129</volume><issue>5</issue><fpage>2133</fpage><lpage>44</lpage><pub-id pub-id-type="pmcid">PMC6486344</pub-id><pub-id pub-id-type="pmid">30985291</pub-id><pub-id pub-id-type="doi">10.1172/JCI126938</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guma</surname><given-names>M</given-names></name><name><surname>Angulo</surname><given-names>A</given-names></name><name><surname>Vilches</surname><given-names>C</given-names></name><name><surname>Gomez-Lozano</surname><given-names>N</given-names></name><name><surname>Malats</surname><given-names>N</given-names></name><name><surname>Lopez-Botet</surname><given-names>M</given-names></name></person-group><article-title>Imprint of human cytomegalovirus infection on the NK cell receptor repertoire</article-title><source>Blood</source><year>2004</year><volume>104</volume><issue>12</issue><fpage>3664</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15304389</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ECY</given-names></name><name><surname>Pjechova</surname><given-names>M</given-names></name><name><surname>Nightingale</surname><given-names>K</given-names></name><name><surname>Vlahava</surname><given-names>VM</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Ruckova</surname><given-names>E</given-names></name><etal/></person-group><article-title>Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><issue>19</issue><fpage>4998</fpage><lpage>5003</lpage><pub-id pub-id-type="pmcid">PMC5948980</pub-id><pub-id pub-id-type="pmid">29691324</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1720950115</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Fanger</surname><given-names>N</given-names></name><name><surname>Borges</surname><given-names>L</given-names></name><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Chin</surname><given-names>W</given-names></name><name><surname>Peterson</surname><given-names>L</given-names></name><etal/></person-group><article-title>A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules</article-title><source>Immunity</source><year>1997</year><volume>7</volume><issue>2</issue><fpage>273</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">9285411</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braud</surname><given-names>VM</given-names></name><name><surname>Allan</surname><given-names>DS</given-names></name><name><surname>O’Callaghan</surname><given-names>CA</given-names></name><name><surname>Soderstrom</surname><given-names>K</given-names></name><name><surname>D’Andrea</surname><given-names>A</given-names></name><name><surname>Ogg</surname><given-names>GS</given-names></name><etal/></person-group><article-title>HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C</article-title><source>Nature</source><year>1998</year><volume>391</volume><issue>6669</issue><fpage>795</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9486650</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>Q</given-names></name><name><surname>Ruckert</surname><given-names>T</given-names></name><name><surname>Borst</surname><given-names>EM</given-names></name><name><surname>Dunst</surname><given-names>J</given-names></name><name><surname>Haubner</surname><given-names>A</given-names></name><name><surname>Durek</surname><given-names>P</given-names></name><etal/></person-group><article-title>Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells</article-title><source>Nat Immunol</source><year>2018</year><volume>19</volume><issue>5</issue><fpage>453</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">29632329</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>BK</given-names></name><name><surname>Barahmand-Pour</surname><given-names>F</given-names></name><name><surname>Paulsene</surname><given-names>W</given-names></name><name><surname>Medley</surname><given-names>S</given-names></name><name><surname>Geraghty</surname><given-names>DE</given-names></name><name><surname>Strong</surname><given-names>RK</given-names></name></person-group><article-title>Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><issue>5</issue><fpage>2878</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">15728498</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Braud</surname><given-names>VM</given-names></name><name><surname>Rickards</surname><given-names>C</given-names></name><name><surname>Powell</surname><given-names>MB</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Gadola</surname><given-names>S</given-names></name><etal/></person-group><article-title>Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40</article-title><source>Science</source><year>2000</year><volume>287</volume><issue>5455</issue><fpage>1031</fpage><pub-id pub-id-type="pmid">10669413</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>McSharry</surname><given-names>B</given-names></name><name><surname>Retiere</surname><given-names>C</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>Borysiewicz</surname><given-names>LK</given-names></name><etal/></person-group><article-title>UL40-mediated NK evasion during productive infection with human cytomegalovirus</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><issue>11</issue><fpage>7570</fpage><lpage>5</lpage><pub-id pub-id-type="pmcid">PMC124287</pub-id><pub-id pub-id-type="pmid">12032324</pub-id><pub-id pub-id-type="doi">10.1073/pnas.112680099</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabat</surname><given-names>J</given-names></name><name><surname>Borrego</surname><given-names>F</given-names></name><name><surname>Brooks</surname><given-names>A</given-names></name><name><surname>Coligan</surname><given-names>JE</given-names></name></person-group><article-title>Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><issue>4</issue><fpage>1948</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">12165520</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mingari</surname><given-names>MC</given-names></name><name><surname>Ponte</surname><given-names>M</given-names></name><name><surname>Bertone</surname><given-names>S</given-names></name><name><surname>Schiavetti</surname><given-names>F</given-names></name><name><surname>Vitale</surname><given-names>C</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><etal/></person-group><article-title>HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen-or alloantigen-activated CD8+ T cells</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><issue>3</issue><fpage>1172</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC18710</pub-id><pub-id pub-id-type="pmid">9448304</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.3.1172</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertone</surname><given-names>S</given-names></name><name><surname>Schiavetti</surname><given-names>F</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Vitale</surname><given-names>C</given-names></name><name><surname>Ponte</surname><given-names>M</given-names></name><name><surname>Moretta</surname><given-names>L</given-names></name><etal/></person-group><article-title>Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes</article-title><source>Eur J Immunol</source><year>1999</year><volume>29</volume><issue>1</issue><fpage>23</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9933082</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fesneau</surname><given-names>O</given-names></name><name><surname>Samson</surname><given-names>KA</given-names></name><name><surname>Rosales</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>B</given-names></name><name><surname>Moudgil</surname><given-names>T</given-names></name><name><surname>Fox</surname><given-names>BA</given-names></name><etal/></person-group><article-title>IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><issue>1</issue><elocation-id>9988</elocation-id><pub-id pub-id-type="pmcid">PMC11574270</pub-id><pub-id pub-id-type="pmid">39557863</pub-id><pub-id pub-id-type="doi">10.1038/s41467-024-54420-w</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Orazio</surname><given-names>JA</given-names></name><name><surname>Stein-Streilein</surname><given-names>J</given-names></name></person-group><article-title>Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes</article-title><source>Clin Exp Immunol</source><year>1996</year><volume>104</volume><issue>2</issue><fpage>366</fpage><lpage>73</lpage><pub-id pub-id-type="pmcid">PMC2200415</pub-id><pub-id pub-id-type="pmid">8625534</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2249.1996.08698.x</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westgeest</surname><given-names>AC</given-names></name><name><surname>Lambregts</surname><given-names>MMC</given-names></name><name><surname>Ruffin</surname><given-names>F</given-names></name><name><surname>Korn</surname><given-names>RE</given-names></name><name><surname>Webster</surname><given-names>ME</given-names></name><name><surname>Kair</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Female Sex and Mortality in Patients with Staphylococcus aureus Bacteremia: A Systematic Review and Meta-analysis</article-title><source>JAMA Netw Open</source><year>2024</year><volume>7</volume><issue>2</issue><elocation-id>e240473</elocation-id><pub-id pub-id-type="pmcid">PMC10900971</pub-id><pub-id pub-id-type="pmid">38411961</pub-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.0473</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>BL</given-names></name><name><surname>Underwood</surname><given-names>J</given-names></name></person-group><article-title>Sex Disparities in Staphylococcus aureus Bacteremia Mortality</article-title><source>JAMA Netw Open</source><year>2024</year><volume>7</volume><issue>10</issue><elocation-id>e2441502</elocation-id><pub-id pub-id-type="pmcid">PMC11525600</pub-id><pub-id pub-id-type="pmid">39476238</pub-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.41502</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emgard</surname><given-names>J</given-names></name><name><surname>Bergsten</surname><given-names>H</given-names></name><name><surname>McCormick</surname><given-names>JK</given-names></name><name><surname>Barrantes</surname><given-names>I</given-names></name><name><surname>Skrede</surname><given-names>S</given-names></name><name><surname>Sandberg</surname><given-names>JK</given-names></name><etal/></person-group><article-title>MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><issue>51</issue><fpage>25923</fpage><lpage>31</lpage><pub-id pub-id-type="pmcid">PMC6926028</pub-id><pub-id pub-id-type="pmid">31772015</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1910883116</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makida</surname><given-names>R</given-names></name><name><surname>Hofer</surname><given-names>MF</given-names></name><name><surname>Takase</surname><given-names>K</given-names></name><name><surname>Cambier</surname><given-names>JC</given-names></name><name><surname>Leung</surname><given-names>DY</given-names></name></person-group><article-title>Bacterial superantigens induce V beta-specific T cell receptor internalization</article-title><source>Mol Immunol</source><year>1996</year><volume>33</volume><issue>10</issue><fpage>891</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">8845021</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>FR</given-names></name><name><surname>Davies</surname><given-names>K</given-names></name><name><surname>Miners</surname><given-names>KL</given-names></name><name><surname>Llewellyn-Lacey</surname><given-names>S</given-names></name><name><surname>Kollnberger</surname><given-names>S</given-names></name><name><surname>Redman</surname><given-names>JE</given-names></name><etal/></person-group><article-title>The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4(+) memory T cells</article-title><source>Commun Biol</source><year>2023</year><volume>6</volume><issue>1</issue><fpage>78</fpage><pub-id pub-id-type="pmcid">PMC9854414</pub-id><pub-id pub-id-type="pmid">36670205</pub-id><pub-id pub-id-type="doi">10.1038/s42003-023-04420-1</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>MR</given-names></name><name><surname>Brenchley</surname><given-names>JM</given-names></name><name><surname>Price</surname><given-names>DA</given-names></name><name><surname>De Rosa</surname><given-names>SC</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Roederer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation</article-title><source>J Immunol Methods</source><year>2003</year><volume>281</volume><issue>1-2</issue><fpage>65</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">14580882</pub-id></element-citation></ref></ref-list></back><floats-group><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Author Summary</title></caption><p>Natural Killer (NK) cells are specialized immune cells that provide crucial defence against viruses but can also respond to bacterial infections, especially in humans. During bloodstream infection by <italic>Staphylococcus aureus</italic>, a Gram-positive bacterial pathogen that causes life-threatening infections in humans, NK cells may actually be harmful, rather than protective, to the host. However, very little is known about the NK cell response to invasive <italic>Staphylococcus aureus</italic> infections in humans. Here, we show that human patients with bloodstream <italic>Staphylococcus aureus</italic>, but not <italic>Escherichia coli</italic>, infections have an increased frequency of NK cells with increased pro-inflammatory capacity. Furthermore, we show that toxins produced by <italic>Staphylococcus aureus</italic>, which help the bacteria evade the protective effects of T cells the immune system (“superantigens”), promoted the expansion of these pro-inflammatory NK cells, providing a possible mechanistic cause for their increased presence in patients with bloodstream <italic>Staphylococcus aureus</italic> infections. Collectively, these results suggest that <italic>Staphylococcus aureus</italic> infection triggers phenotypic and functional changes in NK cells that provide a plausible way to promote inflammation-driven disease pathogenesis</p></boxed-text><fig id="F1" position="float"><label>Figure 1</label><caption><title>Circulating NKG2A<sup>+</sup> NK cells expand <italic>in vivo</italic> during <italic>S. aureus</italic> bacteraemia in humans</title><p id="P39">(A) Schematic overview of study design. (B) Representative flow cytometry plots depicting expression levels of NKG2A vs NKG2C or NKG2A vs CD57 on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls and patients hospitalized with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia. (C-D) Scatter dot plot showing the frequency of NKG2C<sup>−</sup> NKG2A<sup>+</sup> (red filled circles), NKG2C<sup>+</sup> NKG2A<sup>−</sup> (yellow filled circles), CD57<sup>−</sup> NKG2A<sup>+</sup> (green filled circles), or CD57<sup>+</sup> NKG2A<sup>+</sup> (blue filled circles) subsets among CD56<sup>dim</sup> NK cells (C) or CD56<sup>+</sup> T cells (D) from human PBMCs collected from healthy controls and patients hospitalized with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia. Each dot represents one control or patient. Line indicates mean value. *p&lt;0.05; One-way ANOVA with Tukey’s post-hoc test. (E) Scatter dot plots depicting geometric mean fluorescence intensity (gMFI) of NKG2A (green filled circles) or CD57 (red filled circles) expression on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls and patients hospitalized with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia. Each dot represents one donor. Line indicates mean value. **p &lt; 0.05; One-way ANOVA with Tukey’s post-hoc test. (F) Stacked bar charts showing the frequency of CD57<sup>+</sup> or CD57<sup>−</sup> cells amongst NKG2C<sup>+</sup> NKG2A<sup>−</sup> NK cells from human PBMCs collected from healthy controls (<italic>n =</italic> 8) and patients hospitalized with <italic>S. aureus</italic> (<italic>n =</italic> 7) or <italic>E. coli</italic> (<italic>n =</italic> 8) bacteraemia. Data are shown as mean ± SEM.</p></caption><graphic xlink:href="EMS201675-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>The proportion of CD57<sup>+</sup> NKG2C<sup>+</sup> adaptive-like NK cells is lower in patients with <italic>S. aureus</italic> bacteraemia</title><p id="P40">(A) Representative flow cytometry plots depicting expression levels of NKG2A vs NKG2C or NKG2A vs CD57 on NKp30<sup>+</sup> Siglec-7<sup>+</sup> CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls and patients hospitalized with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia. (B-D) Stacked bar charts showing the frequency of NKG2C<sup>−</sup> NKG2A<sup>+</sup>, NKG2C<sup>+</sup> NKG2A<sup>+</sup>, NKG2C<sup>+</sup> NKG2A<sup>−</sup> and NKG2C<sup>−</sup> NKG2A<sup>−</sup> (B), CD57<sup>−</sup> NKG2A<sup>+</sup>, CD57<sup>+</sup> NKG2A<sup>+</sup>, CD57<sup>+</sup> NKG2A<sup>−</sup>, CD57<sup>−</sup> NKG2A<sup>−</sup> (C) or CD57<sup>−</sup> NKG2C<sup>+</sup>, CD57<sup>+</sup> NKG2C<sup>+</sup>, CD57<sup>+</sup> NKG2C<sup>−</sup>, CD57<sup>−</sup> NKG2C<sup>-</sup> (D) subsets among NKp30<sup>+</sup>Siglec-7<sup>+</sup> CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls (<italic>n =</italic> 7) and patients hospitalized with <italic>S. aureus</italic> (<italic>n =</italic> 5) or <italic>E. coli</italic> (<italic>n =</italic> 8) bacteraemia. Data are shown as mean ± SEM.</p></caption><graphic xlink:href="EMS201675-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>TSST-1 promotes the expansion of CD57<sup>−</sup> NKG2A<sup>+</sup> NK cells</title><p id="P41">(A) Representative flow cytometry plots depicting expression levels of NKG2A vs NKG2C or NKG2A vs CD57 on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 24h. (B) Scatter dot plot showing the frequency of NKG2C<sup>−</sup> NKG2A<sup>+</sup> (red filled circles), NKG2C<sup>+</sup> NKG2A<sup>−</sup> (yellow filled circles), CD57<sup>−</sup> NKG2A<sup>+</sup> (green filled circles), or CD57<sup>+</sup> NKG2A<sup>+</sup> (blue filled circles) subsets among CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 24h. Each dot represents one donor. Line indicates mean value. *p &lt; 0.05, ***p &lt; 0.001; Mann-Whitney U-test. (C) Scatter dot plots depicting geometric mean fluorescence intensity (gMFI) of NKG2A (green filled circles) or CD57 (red filled circles) expression on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 24h. Each dot represents one donor. Line indicates mean value. **p &lt; 0.01; Mann-Whitney U-test. (D) Pie charts depicting the proportion of IFN-γ<sup>−</sup> or IFN-γ<sup>+</sup> CD56<sup>dim</sup> NK cells that are made up of subsets that express combinations of CD57, NKG2A and/or NKG2C from human PBMCs that were stimulated with TSST-1 for 24h. Data is concatenated from <italic>n =</italic> 6 individual donors. (E) Frequency of IFN-γ<sup>+</sup> cells among NKG2C<sup>−</sup> NKG2A<sup>+</sup> (red filled circles), NKG2C<sup>+</sup> NKG2A<sup>−</sup> (yellow filled circles), CD57<sup>−</sup> NKG2A<sup>+</sup> (green filled circles), or CD57<sup>+</sup>NKG2A<sup>+</sup> (blue filled circles) CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 24h. Each dot represents one donor. Data are shown as mean ± SEM; *p &lt; 0.05; One-way ANOVA with Tukey’s post-hoc test.</p></caption><graphic xlink:href="EMS201675-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>TSST-1-mediated alterations in NKG2A<sup>+</sup> NK cells are more pronounced over time</title><p id="P42">(A) Representative flow cytometry plots depicting expression levels of NKG2A vs CD57 on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 48h or 72h. (B) Scatter dot plots showing the frequency of NKG2C<sup>−</sup> NKG2A<sup>+</sup> (red filled circles), NKG2C<sup>+</sup> NKG2A<sup>−</sup> (yellow filled circles), CD57<sup>−</sup> NKG2A<sup>+</sup> (green filled circles), or CD57<sup>+</sup> NKG2A<sup>+</sup> (blue filled circles) subsets among CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 48h or 72h. Each dot represents one donor. Line indicates mean value. *p&lt;0.05, **p &lt; 0.01; One-way ANOVA with Tukey’s post-hoc test. (C) Scatter dot plots depicting geometric mean fluorescence intensity (gMFI) of NKG2A (green filled circles), CD16 (yellow filled circles) or CD56 (blue circles filled circles) expression on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 48h or 72h. Each dot represents one donor. Line indicates mean value. *p&lt;0.05, **p &lt; 0.01, ***p&lt;0.001; One-way ANOVA with Tukey’s post-hoc test. (D) Representative overlay histograms showing expression of CD16 or CD56 on CD57<sup>−</sup> NKG2A<sup>+</sup> CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or stimulated with TSST-1 for 48h or 72h. (E) Frequency of Ki67<sup>+</sup> cells among CD57<sup>−</sup> NKG2A<sup>+</sup> (green filled circles), CD57<sup>+</sup> NKG2A<sup>−</sup> (blue filled circles) or CD57<sup>+</sup> NKG2A<sup>−</sup> (black filled circles), CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium (<italic>n =</italic> 7) alone (Unstim) or stimulated with TSST-1 for 48h (<italic>n =</italic> 7) or 72h (<italic>n =</italic> 6). Data are shown as mean ± SEM; *p &lt; 0.05; One-way ANOVA with Tukey’s post-hoc test.</p></caption><graphic xlink:href="EMS201675-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>TSST-1-mediated polarisation towards a CD57<sup>−</sup> NKG2A<sup>+</sup> NK cell phenotype involves an IL-12-independent mechanism</title><p id="P43">(A) Representative flow cytometry plots depicting expression levels of NKG2A vs CD57 on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or pretreated with anti-human IL-12p70 or an isotype control antibody (IgG<sub>1</sub>) before being stimulated with TSST-1 for 48h. (B) Scatter dot plot showing the frequency of NKG2C<sup>−</sup> NKG2A<sup>+</sup> (red filled circles), NKG2C<sup>+</sup> NKG2A<sup>-</sup> (yellow filled circles), CD57<sup>−</sup> NKG2A<sup>+</sup> (green filled circles), or CD57<sup>+</sup> NKG2A<sup>+</sup> (blue filled circles) subsets among CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or pretreated with anti-human IL-12p70 or an isotype control antibody (IgG<sub>1</sub>) before being stimulated with TSST-1 for 48h. Each dot represents one donor. Line indicates mean value. (C) Scatter dot plots depicting geometric mean fluorescence intensity (gMFI) of NKG2A (green filled circles), CD16 (yellow filled circles) or CD56 (blue circles filled circles) expression on CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls that were cultured in medium alone (Unstim) or pretreated with anti-human IL-12p70 or an isotype control antibody (IgG<sub>1</sub>) before being stimulated with TSST-1 for 48h. Each dot represents one donor. Line indicates mean value. *p &lt; 0.05, **p &lt; 0.01; One-way ANOVA with Tukey’s post-hoc test.</p></caption><graphic xlink:href="EMS201675-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>CD56<sup>dim</sup> NK cells in human patients with <italic>S. aureus</italic> bacteraemia are more polyfunctional, yielding more effector cytokines upon stimulation</title><p id="P44">(A) Frequency of CD107a<sup>+</sup> cells among CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls (black filled circles) and patients hospitalized with <italic>S. aureus</italic> (blue filled circles) or <italic>E. coli</italic> (red filled circles) bacteraemia cultured in medium alone (Unstim) or with PMA/Ionomycin for 6h. Data are shown as mean ± SEM; **p &lt; 0.01, One-way ANOVA with Tukey’s post-hoc test. (B) Representative flow cytometry plots depicting expression levels of CD107a and IFN-γ among CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls and patients hospitalized with <italic>S. aureus</italic> or <italic>E. coli</italic> bacteraemia cultured in medium alone (Unstim) or with PMA/Ionomycin for 6h. (C) Frequency of CD107a<sup>+</sup> IFN-γ<sup>+</sup> cells among CD56<sup>dim</sup> NK cells from human PBMCs collected from healthy controls (black filled circles) and patients hospitalized with <italic>S. aureus</italic> (blue filled circles) or <italic>E. coli</italic> (red filled circles) bacteraemia cultured in medium alone (Unstim) or with PMA/Ionomycin for 6h. Data are shown as mean ± SEM; *p &lt; 0.05, One-way ANOVA with Tukey’s post-hoc test. (D) Functional profiles of CD56<sup>dim</sup> NK cells from human PBMCs stimulated with PMA/Ionomycin for 6h. Pie chart segments from concatenated data (n = 7 - 8) represent the fraction of cells displaying the indicated number of functions (key). Arcs denote individual functions (key).</p></caption><graphic xlink:href="EMS201675-f006"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Baseline demographics of adult patients hospitalized with <italic>S. aureus or E. coli</italic> bacteraemia compared to healthy controls.</title><p>Abbreviations: SOFA: sequential organ failure assessment. CRP: c-reactive protein. Diagnosis indicates positive blood culture for <italic>S. aureus</italic> or <italic>E. coli</italic></p></caption><table frame="below" rules="groups"><col/><thead><tr><th align="center" valign="middle"/><th align="center" valign="middle"><italic>S. aureus</italic> bacteraemia</th><th align="center" valign="middle"><italic>E. coli</italic> bacteraemia</th><th align="center" valign="middle">Healthy controls</th></tr><tr><th align="center" valign="middle"/><th align="center" valign="middle">(<italic>n</italic> = 7)</th><th align="center" valign="middle">(<italic>n</italic> = 8)</th><th align="center" valign="middle">(<italic>n</italic> = 8)</th></tr></thead><tbody><tr><td align="left" valign="middle"><bold>Age</bold></td><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/></tr><tr><td align="left" valign="middle">Median</td><td align="center" valign="middle">63.2</td><td align="center" valign="middle">68.0</td><td align="center" valign="middle">66.7</td></tr><tr><td align="left" valign="middle">Range</td><td align="center" valign="middle">27.6 - 79.2</td><td align="center" valign="middle">31.6 - 74.9</td><td align="center" valign="middle">59.4 - 72.4</td></tr><tr><td align="left" valign="middle"><bold>Sex</bold></td><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/></tr><tr><td align="left" valign="middle">Female</td><td align="center" valign="middle">7</td><td align="center" valign="middle">6</td><td align="center" valign="middle">3</td></tr><tr><td align="left" valign="middle">Male</td><td align="center" valign="middle">0</td><td align="center" valign="middle">2</td><td align="center" valign="middle">5</td></tr><tr><td align="left" valign="middle"><bold>SOFA SCORE</bold></td><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/></tr><tr><td align="left" valign="middle">&lt;2</td><td align="center" valign="middle">3</td><td align="center" valign="middle">3</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle">≥2</td><td align="center" valign="middle">4</td><td align="center" valign="middle">5</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle"><bold>CRP at admission</bold></td><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/></tr><tr><td align="left" valign="middle">Median</td><td align="center" valign="middle">250</td><td align="center" valign="middle">216</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle">Range</td><td align="center" valign="middle">12 - 383</td><td align="center" valign="middle">51 - 433</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle"><bold>Time of sampling (days post-diagnosis)</bold></td><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/></tr><tr><td align="left" valign="middle">Mean</td><td align="center" valign="middle">4.0</td><td align="center" valign="middle">3.1</td><td align="center" valign="middle">-</td></tr><tr><td align="left" valign="middle">Median</td><td align="center" valign="middle">4</td><td align="center" valign="middle">3</td><td align="center" valign="middle">-</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle">Range</td><td align="center" valign="middle">2 - 6</td><td align="center" valign="middle">24</td><td align="center" valign="middle">-</td></tr></tbody></table></table-wrap></floats-group></article>